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“True education does not consist merely in the acquiring of a few facts of science,
history, literature, or art, but in the development of character.”
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Abstract
Optical biosensors, and in particular label-free optical biosensors have be-
come one of the most active and attractive fields within the biosensing de-
vices. The portability and the possibility to set free from the laboratory
settings gave a new hint for integrated photonic biosensors development
and use in numerous applications. Integrated photonic sensors have shown
very promising results, and in particular, devices like WGM resonators and
interferometers are showing high sensitivities and miniaturization abilities,
which allow the realization of an integrated complete lab-on-chip device.
The main goal of my thesis is the development of an optical biosensor for
the fast and comprehensive detection of carcinogenic Aflatoxin M1 (AFM1)
mycotoxin. The acceptable maximum level of AFM1 in milk according to
European Union regulations is 50 ng/L equivalent to 152 pM for the adults
and 25 ng/L equivalent to 76 pM for the infants, respectively.
Within a European Project named SYMPHONY, we develop an inte-
grated silicon-photonic biosensor based on the optical microring resonators
(MRR) and the asymmetric Mach-Zehnder Interferometers (aMZI). The sens-
ing is performed by measuring the resonance wavelength shift in the MRR
transmission or the phase shift of aMZI caused by the binding of the analyte
to the ligand immobilized on the sensor surface. These measurements were
my principal task within the project.
The experimental characterization of the bulk refractometric sensing of
the devices is performed in a continuous flow. This characterization assesses
the high resolution of both device types, which are able to resolve variations
in the refractive index of the liquids with a limit of detection down to 10−6
refractive index units (RIU).
Furthermore, the SYMPHONY sensor optimization based on the Fab’
and DNA-aptamer functionalization strategies is realized. It is therefore
viii
demonstrated, that the Fab’ functionalization strategy provides more repro-
ducible results with respect to the DNA-aptamer one. However, for both
strategies, the specificity of the sensor functionalization to detect AFM1
molecules is achieved with respect to non-specific Ochratoxin molecules at
high concentrations.
In the final stage of the SYMPHONY project, the Fab’-based function-
alized aMZI sensor is tested with real milk samples (eluates) prepared in
the SYMPHONY system that consists of the three main modules: the defat-
ting module, the concentrator module and the sensor module. The system
calibration yields the minimum concentration of AFM1 at 40 pM to be de-
tectable.
The detection of the ligand-analyte binding in real-time enabled the study
of the kinetics of the binding reaction, and we measured for the first time the
kinetic rate constants of the Fab’-AFM1 interaction with our sensors.
Finally, a MRR based affinity biosensor is developed dedicated to the
biotinylated BSA - anti-biotin binding study. An affinity constant of 106
M−1 is measured. The sensor is successfully regenerated up to eight times
by applying longer incubation period.
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Introduction
1.1 Thesis Structure
This thesis is structured into four chapters.
Chapter 1 gives the introduction of the problem, existing solutions and
the key components of the biosensors for mycotoxin detection. Then I in-
troduce different types of the optical biosensors, in particular SPR, waveg-
uide and fiber based evanescent sensors. This chapter is concluded with the
state-of-the-art of the optical sensors for later comparison with the devices
developed during my PhD.
Chapter 2 gives a general theoretical background, that entails the mod-
els and equations used to describe the MRR and aMZI based biosensors. It
covers both the description of the kinetic of the binding reactions, that selec-
tively recognize the analyte molecules, and the description of the photonic
sensors, that transforms the binding to a measurable signal.
Chapter 3 reports on the development and characterization of the exper-
imental apparatus. Here, I have optimized and tested optical setups, for the
precise and stable measurement of the three different photonic sensors used
in this thesis which are based on MRR (fabricated in FBK and LioniX) and
aMZI (fabricated in LioniX) at 850 nm. Therefore, the setup for SYMPHONY
MRR devices was initially realized by Dr. Davide Gandolfi. In the conclu-
sion of the chapter, I present the final integration of the SYMPHONY system
realized by me.
Chapter 4 is dedicated to the results and discussions. In particular, in
§ 4.1 the experimental results on the MRR based sensors, developed within
SYMPHONY project are presented. This device is designed by Dr. Davide
Gandolfi and Dr. Romain Guider, and fabricated by Dr. Alina Samusenko.
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The results on the optical characterization of the MRR based photonic chips
and the bulk sensitivity measurements that are reported in § 4.1.1 and § 4.1.2,
respectively, as well as some of the results in § 4.1.3 are obtained by me and
Dr. R. Guider. The functionalization of the MRR based biosensors, both with
DNA-aptamers and Fab’, is performed by Dr. Laura Pasquardini.
In § 4.2 all the experimental results presented for aMZI based sensors are
obtained by me. Surface functionalization is done by Dr. Cristina Potrich in
LABSSAH, FBK. The optical and bulk sensitivity characteristics of the sen-
sors are demonstrated. First, the sensing of AFM1 in buffer solution is real-
ized with the Fab’ functionalized aMZI sensors. For Fab’-AFM1 molecular
interaction the affinity and dissociation constants in buffer are calculated.
Finally, AFM1 detection in real milk samples and the sensor calibration are
reported in § 4.2.5 and § 4.2.6, respectively.
The last § 4.3 of this chapter is dedicated to the results, obtained during
my internship in LioniX. Under the supervision of Dr. Geert Besselink, I
developed an affinity biosensor based on the multi MRR photonic chips for
the biotinylated BSA and anti-biotin interaction studies. Binding constants,
as well as the affinity of the sensor are measured. The sensor regeneration
to eight times is realized.
Appendix A shortly reports on the preparation of the buffers and regen-
eration solutions, as well as materials used both in the studies of AFM1 and
anti-biotin. While Appendix B shows the steps of milk sample preparation
in the SYMPHONY system, i.e. fat removal and concentration details.
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1.2 Biosensor
"Any device that has specific biochemical reactions to detect chemical compounds
in biological samples..."
Leland Clark
"Father" of Biosensors
A biosensor is a complex integrated device providing a specific quan-
titative or relative analytical information on a sample through a biological
recognition element which is in direct spatial contact with a transduction el-
ement [1]. It is a manifold system connecting different fields such as biology,
chemistry, optics, electronics, informatics in a single device. In 1975 the first
commercial biosensor to analyte whole blood glucose content was reported
[2]. Since then, the biosensors technology started, by the development of
different components of the whole system, improving the performance and
the specificity of biosensors, as well as including new targets for detection.
Figure 1.1 shows the key components of any biosensing device.
Ligand
Aptamer Antibody Enzyme
Analyte
DNABiomolecules Viruses
Transducer Element
Electro-Chemical Piezoelectric
Optical
Label-free Fluorescent
Amplifier
Signal Processing
FIGURE 1.1: Key components of a biosensor1. The transducer receives a signal
from a ligand-analyte reaction which is read as an electrical/optical signal in
real-time.
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In order to detect the target molecules, i.e., the analyte, the transducer
element is immobilized (activated) with specific molecules, so called ligand
or receptor, that can react with the analyte. In this way, the biomolecular in-
teraction of the analyte and ligand/receptor is sensed by the transducer and
a signal, which can have electro-chemical [3], optical [4] origin is generated.
In particular, in this thesis an optical transducer based on silicon is stud-
ied. Silicon based mass-production and low-cost technologies, such as sili-
con photonics, are attractive by providing a possibility of a biosensor fabri-
cation in which reaction and analysis take place in a single device.
In recent years a class of electro-chemical transducers, based on graphene,
is suggested to become the cheapest technology for sensing applications,
thanks to the easy and accessible fabrication of graphene using graphite.
This new generation of biosensors is already applied in the detection of var-
ious analytes, in the field of clinical, environmental and food research [5].
Other examples of transducers are microelectrodes arrays (MEA) [6],
which have applications in impedance spectroscopy, in recording the neural
activity in-vitro and in-vivo, and microelectromechanical systems (MEMS)
[7]. Lastly, microcantilevers [8] and quartz- crystalmicrobalances (QCMB)
[9], that perform gravimetric sensing exploiting the change in resonance fre-
quency of a vibrating piezoelectric crystal [10] need to be mentioned.
The variety of analytes is growing very fast, depending on applications,
such as health control, food safety, environment monitoring, drug deliv-
ery. Day-by-day, appearance of new viruses, toxins, new DNA mutations
demand proper ligands to observe them. In order to fulfill these needs of
selective recognition, also different kinds of ligands have to be explored. Se-
lectivity is the ability of a (bio-)sensor to recognize preferentially a certain
analyte, or class of analytes, even in presence of other interfering species.
According to the International Union of Pure and Applied Chemistry (IU-
PAC) definitions [11, 12], specificity is the ultimate of selectivity i.e., the
ability of the sensor to respond only to its target. The most known and wide
1The parts of the picture are taken from:
viruses (https://goo.gl/L8efxU), aptamer (https://goo.gl/zGCyaF),
antibody (https://goo.gl/cs28XW), enzyme (https://goo.gl/NrkfrF),
electro-chemical (https://goo.gl/B9yKKs), piezoelectric (https://goo.gl/aYfe8a),
label-free (https://goo.gl/VKxeV9), fluorescente (https://goo.gl/y3942p),
amplifier (https://goo.gl/ddg8zC)
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spread ligands are enzymes, aptamers, particularly DNA and RNA, anti-
bodies etc. Antibodies have been employed in molecular bio-recognition
since 1950s and they are exposed in the heart of immunoassays. Their many
characteristics, like diversity, high affinity, well studied regeneration meth-
ods of antibodies, undeniably make them a powerful biorecognition ele-
ment [13]. At the same time, aptamers and, mainly, DNA-aptamers emerge
as competitors in the field of in-vitro diagnostics [14]. Thanks to their small
dimensions, they are suitable for a high-density coverage of the sensor. In
addition, aptamers are stable to long-term storage.
There is a continuous challenge for the development of biosensors and
technologies that are able to simultaneously detect multiple biological ma-
terials, from whole cells to single molecules, with increasing capabilities. In
addition, depending on the detection approaches, we can define two groups
of biosensors: labeled and label-free. While the labeled detection requires a
secondary molecule or an amplification step, label-free detection enables
the sensors to directly detect the molecule of interest after the capture reac-
tion [15]. An example of labeled detection method is the fluorescence mi-
croscopy where target biomolecules are stained (labeled) with fluorescent
markers to increase the resolution and the contrast of the microscope im-
age. Despite the fact that labeled detection methods have the advantage of
the dual-confirmation of the presence of the analyte thanks to the secondary
molecule, which reduces false-positive readings, the secondary molecule in-
troduces an additional time-consuming step, thus making labeled detection
methods not suitable for rapid and real-time sensing applications. On the
other hand, the quantitative analysis are challenging due to the fluorescence
signal bias, as to each molecule belong to number of fluorophores that can-
not be precisely controlled [16], thus making the fluorescence-based biosen-
sors applicable in cases when pure solutions are studied. Nevertheless, for
the biomolecular interaction studies, affinity characterizations, the presence
of a label, might affect the interaction process. In this case, the use of a label-
free technique is preferable. Label-free Biomolecular Interaction Analysis
(BIA) is a powerful technique to study the chemical binding of molecules
in real-time. BIA is an important method for drug discovery and drug de-
velopment [17]. Finally, label-free approach is more economic, as it does
not require additional labeling step and is applicable for small volumes of
analyte studies.
During the past years, concerns were raised on the portability and on
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the possibility of freeing biosensors from the laboratory settings. This re-
quires the sensor integration with microfluidics and the realization of a com-
plete integrated lab-on-a-chip device [18]. The role of microfluidic systems
is highly important, since they take control of flow conditions, mixing rates
of different reagents, as well as of reducing sample and reagents volume
[19]. In fact, lab-on-a-chip is a term for devices that integrate (multiple) lab-
oratory functions on a single chip of only millimeters to a few square cen-
timeters total area and that are capable of handling extremely small fluid
volumes down to less than picoliters. Figure 1.2 is an ideal demonstration
of the idea of a lab-on-a-chip device.
FIGURE 1.2: Lab-on-a-chip principle2.
There are many applications where a highly integrated lab-on-a-chip de-
vice could be of particular interest. Therefore, lab-on-a chip devices became
more prominent after the evolution of Complementary Metal Oxide Semicon-
ductor (CMOS), a standard fabrication technology for silicon-based micro-
electronics which expanded the development of multidisciplinary,integrated
2The picture is taken from http://www.gene-quantification.de/lab-on-chip.html
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sensing platforms, by taking advantage of several favorable optical proper-
ties of silicon, such as the high refractive index, that enables the realiza-
tion of small optical components [20]. The easy fabrication with CMOS pro-
cesses, fosters a low cost for eventual mass production of Silicon On Insula-
tor (SOI) wafers. Spectral properties of the material allow silicon photode-
tectors and waveguides fabrication to operate next to each other on a single
platform. The particularity of multiplexing capabilities of an integrated lab-
on-a-chip biosensor permits screening of the target sample against several
markers, thus increasing accuracy and speed of detection. This approach,
for example, is used for the recognition of particular diseases or for pharma-
ceutical researches [21]. The possibility of real-time monitoring of reaction
kinetics offered by these type of biosensors, makes them indispensable tool
in drug screening and development industry. These devices find a use not
only in the medical diagnostics or in specialized laboratories, but in point-
of-care instrumentations [22], as well as for the environmental and pollution
monitoring, where lab-on-a-chip biosensors can be used to detect bacteria,
chemical compounds or heavy metals [23], present in the atmosphere, in
the soil or in the water directly in nature. Another application of lab-on-
a-chip biosensors, and perhaps in recent days, a highly demanding one, is
in the field of security and counter terrorism. Small traces of chemical and
biological warfare agents, life-threatening gases can be detected in airports,
stadiums and other critical safety scenarios [24].
Finally, we recall the application of the lab-on-a-chip label free biosen-
sors that is one of the goals of my thesis, i.e., food safety control. Biosensors
are used in detection of contaminants in the food industries, such as pes-
ticide, toxin, mutated DNA sequence, etc. Here, we mainly focus on the
study of a lab-on-a-chip optical biosensor immobilized with the antibod-
ies or DNA-aptamers, for a label-free detection of mycotoxins, in particular
Aflatoxin M1 in milk.
1.2.1 Mycotoxins
For a biosensor development the first important step is to understand the
target molecule which has to be detected. Understanding the nature of the
analyte permits to select proper ligands and construct sensitive tool for the
detection. Here, we will concentrate on mycotoxins, in particular aflatoxins,
that are present in milk and dairy products.
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Contamination of food and agricultural products by various types of
toxigenic molds (fungi) is a serious and a global problem that becomes a
subject of many researches in increasing number of countries. Studies showed
that approximately 25% of the crops in the world get contaminated by molds
and are affected by mycotoxins [25], causing the economic loss of billions of
dollars. Climatic conditions, such as rain, humidity, heat etc., can stimulate
fungal growth, as well as poor harvesting practices, improper drying, han-
dling, packaging, storage, and transportation conditions contribute to the
process and increase the risk of mycotoxin production. Fungal toxins have
been detected in various food commodities from many parts of the world
and have been recognized to be one of the most dangerous contaminants
[26] that affect human and animal health.
Mycotoxins are produced by some of the specific strains of filamentous
fungi belonging to species of the genera Aspergillus, Penicillium, and Fusar-
ium that affect crops at the field level and may grow on food during storage
under certain favorable conditions. Mycotoxins are considered as “risk fac-
tor” to humans highly depending on the toxicity of the mycotoxin, the dose
involved and the extent of the exposure. Since 1960, nearly 400 types of my-
cotoxins have been discovered. From the point of view of health, the impor-
tant mycotoxins in human and animal food include: aflatoxins, ochratoxin,
trichothecenes, fumonisins, and patulin.
1.2.1.1 Aflatoxins
Aflatoxins are highly toxic, mutagenic, teratogenic and carcinogenic com-
pounds that are produced as secondary metabolites by fungi belonging to
several Aspergillus species, mainly A. flavus and A. parasiticus [27, 28].
Aflatoxins have a high presence in tropical and subtropical regions where
humidity and temperature conditions are optimal for toxin production. The
name "aflatoxin" comes from the combination of “a” for the Aspergillus
genus, “fla” for the species flavus, and ends with the word toxin, because of
its toxicity. The severe outbreak of turkey “X” disease (in the U.K.) that re-
sulted in the death of more than 100000 turkeys and other farm animals, in
1960s, led to the discovery of aflatoxins. The cause was attributed to Brazil-
ian peanuts fed to the animals, which was contaminated with A. flavus.
Aflatoxins are found in a wide range of agricultural products, including ce-
reals (maize, rice, wheat), spices (chillies, black pepper, ginger), tree nuts
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(almond, pistachio, walnut, coconut), milk (human and animal), and butter
(see Figure 1.3). The fact that the listed products are used in everyday life,
makes aflatoxins even more dangerous.
Different types of aflatoxins have been identified wherein the major ones
include aflatoxin B1, B2, G1, G2, and M1. Fungal species belonging to As-
pergillus flavus typically produce AFB13 and AFB2, whereas A. parasiticus
produces AFG1 and AFG2 as well as AFB1 and AFB2. These aflatoxins are
classified by International Agency for Research on Cancer (IARC) as Group
1 carcinogens [29].
(a) (b)
(c)
FIGURE 1.3: (a) Maize cob and (b) peanuts colonized by Aspergillus species4.
(c) Chemical conversion of AFB1 to AFM1.
3Aflatoxins are labeled as AF+the type, for example AFB1.
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Less toxic AFM1 that is present in milk is a result of AFB1 mutation
in animal (caw, sheep, goat) organism. Figure 1.3c shows the steps of the
chemical conversion of AFB1 to AFM1 [30]. It is generally recognized that
contamination of milk and milk products with AFM1 varies according to
geographical location (dry or wet) and season (hot or cold).
Since most of the human species, as well as animals, particularly the
young nurturing ones, are dependent on milk as a part of complete basal
nutrition, AFM1 contamination in milk and its products are of extreme im-
portance and is a serious problem. In 1993 the IARC categorized AFM1 as
a 2B human carcinogen [31]. Later, the European Commission regulation
(EC) No. 1881/2006 specified the maximum level of AFM1 contamination
in milk to 50 ppt (50 pg/ml), and to 25 ppt (25 pg/ml) for infant formulae.
However, a long-term consumption of AFM1 at low levels (ppb) may lead
to the development of hepatocellular cancer. Aflatoxins are perceived to be
co-factors in the higher incidence of liver cancer (hepatocellular carcinoma)
along with hepatitis-B virus for instance [32].
1.2.2 Aflatoxin M1 detection techniques
Many methodologies have been researched to remove AFM1 from milk by
adsorption using bentonite, applying ultraviolet radiation, humic acids etc.
However, AFM1 is know to be resistant against chemical and thermal treat-
ments [33]. Consequently, it is highly important to detect and eliminate
contaminated milk immediately after getting it from animals. Numerous
techniques have been developed for this purpose.
1.2.2.1 High Performance Liquid Chromatography (HPLC)
The generally accepted method for the detecting of Aflatoxin M1 in milk is
the High Performance Liquid Chromatography (HPLC) [13, 34]. The HPLC
instrumentation consists of few fundamental parts. First, the mobile phase,
i.e., the solution, which contains the target particles, held in solvent reser-
voirs, is pumped through the system by one or more pumps at a constant
4The pictures are taken from:
(a) https://goo.gl/NU63jz, (b) http://aquafind.com/articles/Mycotoxin.php
1.2. Biosensor 11
flow rate and delivered to the specific column under high pressures (400 at-
mosphere) [35]. The HPLC column is composed of a metal or plastic cylin-
der, that contains a packing of small porous particles with a second phase
bound to the surface [36]. The solution, flowing in the column, is called
a stationary phase. The sample mixture flows through the packed particle
bed at a constant flow rate. During the flow, each component of the mixture
interacts with the stationary phase at a different rate, thus causing the sam-
ple separation. Next, the separated components are eluted and moved into
a detector cell. Detection is realized by absorption spectroscopy at a wave-
length of 220 nm. A quantitative information about the initial amount of
the target compounds can be extracted from a chromatogram, which gives
a dependence of the intensity, corresponding to each component, from the
elution time.
HPLC is used for confirmation and precise quantification of AFM1 present
in milk after it has been detected by other relatively fast techniques. HPLC is
an expensive technique to perform, mainly due to the cost of the instrumen-
tation and the cost of employment of technical operators. In particular, in
countries where the level of AFM1 is the highest (India, African countries),
the possibility to examine milk with HPLC is less probable.
1.2.2.2 Thin Layer Chromatography (TLC)
Thin Layer Chromatography (TLC) method is older (first time used in 1966)
than HPLC and has several advantages. It is far cheaper than HPLC meth-
ods and it does not require extensively trained operators, however it is less
accurate than HPLC [37]. TLC with fluorescence detection was applied for
ultimate separation of the aflatoxin spots from the background, detection,
and quantification. In this method, ultra-violet light is used for the detec-
tion and the typical monitoring of the presence of AFM1 in a blue fluorescent
line. In developing countries TLC is the preferred detection technique due
to the low cost and ease of use.
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1.2.2.3 Enzyme Linked ImmunoSorbant Assay (ELISA)
The most common technique for AFM1 detection in milk (even if not an ac-
creditate method) is the ELISA (Enzyme Linked ImmunoSorbant Assay), in-
troduced in 1971, by Peter Perlmann and Eva Engvall at Stockholm Univer-
sity in Sweden [38]. It is a plate based assay. The general concept of ELISA,
particularly for AFM1 detection, is the following: the assay is performed
by adding AFM1 standard controls and samples to anti-AFM1 monoclonal
antibody-coated wells. Then the plate is left to incubate for 20 minutes.
During this time the AFM1 molecules bind to the antibody. After the first
washing step, AFM1 that has been conjugated to horseradish peroxidase
(AFM1-HRP) is added and incubated for 10 more minutes, thus allowing
the conjugate to bind to any remaining unbound antibody. After the second
washing step, substrate is added, which reacts with the bound conjugate to
produce blue color. The color development is inversely proportional to the
AFM1 content in the sample, i.e., more blue color means less AFM1. The in-
tensity of color/ optical density is measured at 450 nm. A calibration curve
is obtained be plotting the optical densities of the standard solutions.
The advantages of the ELISA technique are the fast analyses and the cost
of the equipment required [39]. However, a positive ELISA result needs
to be verified by HPLC. Frequently, ELISA method yields higher concen-
trations than those obtained by HPLC. The origin of this mismatching can
be a fake signal due to the cross-reaction between antibodies and proteins
present in milk [13].
1.2.2.4 Bilayer Lipid Membranes (BLM)
Another reliable technique for AFM1 detection in milk is Bilayer Lipid Mem-
branes (BLM), classified as a non immunochemical technique [40]. BLM
based biosensors are meant for laboratory use by specialized personal. They
are attractive thanks to fast analyses durations of approximately 15 seconds.
The idea of BLM technique is quite simple. As a consequence of the interac-
tion of AFM1 and a lipid membrane, channels in the lipid membrane open
and allow the eluent to pass through. The eluent is an ionic solution so that
changes in ion concentration can be monitored using an electrochemical de-
tector. By controlling the flow rate it is also possible to eliminate protein
interferences that usually give a non-specific and fake response. The great
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advantage of this technique is the possibility of multiple use of lipid mem-
branes. The cost of the equipment is much lower than HPLC.
1.2.2.5 Rapid One Step Assay (ROSA)
Besides the listed detection techniques, which are widely used in all over
the world, a fast and simple way of the AFM1 detection in milk is devel-
oped by the Charm Sciences Inc. The Rapid One Step Assay (ROSA)5 is a
lateral flow test that can be run using the Charm EZ system or ROSA Pearl-
X Reader. ROSA realizes the AFM1 quantitative detection at the US FDA
action level of 0.5 ppb (500 ppt) in dairies and food manufacturers. The
duration of the test is 8-minutes. After the 8-minutes incubation with the
ROSA incubators which provide the exact temperature and time needed for
each test reaction, the Charm EZ reads and displays the result of the test as
"Negative" or "Positive".
By the same equipment it is possible to test the presence of different
antibiotics in milk as well.
1.2.2.6 Summary of AFM1 detection methods in milk
Besides the commercially available detection methods, there are several other
techniques for the AFM1 detection in milk. One example of the AFM1 de-
tection system is a gold microelectrode array (MEA) immunosensor accom-
plished with ELISA [6]. Other detection system based on a competitive
immunoassay using horseradish peroxidase (HRP) as a tag and the mag-
netic nanoparticles coated with anti-AFM1 antibody in order to separate the
bound and unbound fractions of milk sample is reported [41]. Immunoas-
says have application also in the membrane-based flow-through enzyme
immunoassay sensors for the AFM1 detection since 1999 [42].
Even though the immunological techniques have many advantages such
as relatively rapid and sensitive analysis, however, they are limited by their
elevated cost. As alternatives, the aptamer based sensing technologies are
developed. Recently, the magnetic nanoparticles immobilized with the DNA-
aptamers have been employed in the sensing platform for the AFM1 detec-
tion in a range of 20 and 1000 ng/kg concentrations [43].
5https://www.charm.com/rosa-lateral-flow-antibiotic-strip
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Table 1.1 summarizes the lowest detectable concentrations of AFM1 mon-
itored by the described approaches.
TABLE 1.1: Laboratory based techniques for Aflatoxin M1 detection in milk.
LOD shows the limit of detection.
Technique name AFM1 LOD ∼Duration Reference
(ppt) (hours)
HPLC 4.5 72 [34, 44]
TLC 5 4-5 [45]
ELISA 4.3 3 [39, 46]
BLM 16 0.5 [40]
ROSA 500 0.15 [47]
MEA 8 2 [6]
Electrochemical 10 0.5 [41]
Field Immunoassay 50 3 [48]
DNA-aptasensor 20 4 [43]
SPR 0.6 2 [42]
One can notice, that among the listed techniques, except the last one, i.e.,
Surface Plasmon Resonance (SPR), all the others are based on fluorescence
or electrochemical detection mechanism. The name of the SPR method, al-
ready indicates its origin to be an optical sensor. The next section is com-
mitted to the optical biosensors, which are based on the evanescent field
sensing mechanisms.
1.2.3 Optical biosensors
The first optical sensors came into sight in 1937, when Langmuir and Schae-
fer described the determination of a biomolecule adlayer thickness formed
on a metallic surface via the observation of colors produced by reflective in-
terference [49]. However, the real outbreak of optical biosensors occurred
in the mid-90s with the development and realization of micro-fabrication
technologies and detection systems. Since then, optical biosensors, in par-
ticular label-free optical biosensors, have become one of the most attractive
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biosensing devices thanks to a number of unique characteristics such as the
use of light, which rules out electrical interference, and the excellent bio-
analytical performance. The choice of the transducer is dictated by several
fundamental parameters that leads to the prioritization of one or the other
detection method. The most obvious one is the limit of detection (LOD) [50,
51], which can be defined as the smallest detectable concentration of the tar-
get analyte or the lowest detectable molecular mass of the target molecules,
or the lowest detectable surface mass density of the target substance. Thanks
to the possibility of miniaturization, optical biosensors can be utilized to
test small (down to few microliters) sample volumes. This point sometimes
can be crucial if the sample volume is available in very limited amounts
(e.g., human drug targets) or the transducer is integrated with other pro-
cesses delivering small sample amounts. Optical biosensors are winners in
terms of simultaneous multiple sensing possibilities in short detection time.
The more multiplexed a sensor, the more parallel tests can be performed
at the same time, keeping the equipment size and cost to the minimum. A
wide range of transducer principles was developed in the last three decades.
Next, a few of the most important types of the optical biosensors, i.e., SPR,
waveguide and fiber based sensors are described.
1.2.3.1 Surface Plasmon Resonance (SPR)
A wide class of optical label-free biosensors is based on a surface plasmon
resonance (SPR) phenomena. It is the most popular and commercialized
optical biosensor technology today. This technology provides binding, ki-
netics, affinity, specificity and concentration, without any need of labelling.
Surface plasmon resonance was demonstrated for the first time by Liedberg
in 1983 [52], even though the basic phenomenon was already described by
Kretschmann since 1968 [53]. A surface plasmon wave (SPW) is a charge
density oscillation occurring at the boundary of two media with dielectric
constants of opposite signs, such as a metal (gold or silver) and a dielectric.
The SPR method is based on the change in the SPW resonance caused by
the change in the refractive index of one of the two medias. In any SPR con-
figuration, the incident light totally reflects from the dielectric-metal surface
and generates an evanescent field penetrating into the metal layer. Under
certain angles or wavelengths, the propagation constant of the evanescent
field matches with SPW, resulting in a resonance coupling of the incident
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light with SPW. This yields an intensity loss in the output reflected light and
the appearance of a characteristic negative peak (deep) in the intensity pro-
file of the reflected light as a function of the incident angle. The position of
the deep, and consequently of the resonance angle, is correlated with the re-
fractive index near to the metal surface. Thus, a change in the surrounding
environment yielding a change in the refractive index causes the displace-
ment of the resonance angle which is measured by the shift of the intensity
deep. In particular, using a metal surface as a layer for ligand molecules
immobilization, and flowing a target solution over that layer, the molecu-
lar binding event can be monitored by recording the angular position of the
intensity deep [54].
Among various SPR configurations, based on a light coupling technique,
such as prism coupling, waveguide coupling, fiber optic coupling or grating
coupling, the most convenient one to get the lowest sensing limit of detec-
tion is the prism based method, even though it is bulky and creates several
challenges for integration in a compact lab-on-a-chip device. Waveguide
coupling is a good alternative and in contrast to the prism, it is easily inte-
grable. Figure 1.4a shows the SPR prism configuration working principle.
(a) (b)
FIGURE 1.4: (a) The angle of reflected intensity changes when target molecules
bind to the molecules immobilized on the surface of the gold layer and, there-
fore, changes the refractive index6. Decrease of intensity is real-time monitored
and represented as a sensorgram. (b) SPR GE Biacore T200 commercial system.
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Numerous commercial apparatuses exist based on the SPR method. The
most known and commonly used are the Biacore7 instruments that are to-
tally automated so that the analysis and the sensor regeneration is com-
puter controlled. The sensor chip in Biacore systems, consists of a glass slide
coated with gold. Figure 1.4b shows an example of the commercial Biacore
T200 system8. Biacore apparatus permits to monitor binding events between
molecules ranging from ions to viruses.
SPR is also used for mycotoxin, in particular aflatoxins detection. Several
works reported low limits of detections for AFM1 (see Table 1.1) and AFB1
in milk [42, 55, 56].
1.2.3.2 Waveguide based biosensors
Waveguide based optical biosensors represent a large class of detection mech-
anisms, that includes variety of optical structures, such as interferometers,
resonators, etc. The introduction of the waveguides by Colladon dates back
to 1842, who experimentally showed that due to total internal reflection
(TIR), the light can be guided in a transparent material with refractive in-
dex higher than its surrounding environment (nsubstrate< ncore >nclad) [57].
By using waveguides, the light path can be simply controlled without the
necessity of using bulky components like mirrors or beam splitters (see Fig-
ure 1.5a). In particular what is interesting for my work, is that light propa-
gation through waveguides offers excellent possibilities for sensing.
In fact light propagates through the waveguide according to particular
patterns of the electromagnetic field, called guided modes [58]. In a slab
waveguide the electrical component of the guided mode is given by:
E¯i(x, z,ω, t) = E¯0i (x,ω) exp[j(ωt− β˜iz)] , (1.1)
where z is the propagation direction and x is the direction where the refrac-
tive index step profile occurs.
6The picture is from https://goo.gl/WzUdGz.
7https://www.gelifesciences.com/en/ae/solutions/protein-research/products-and-
technologies/spr-systems
8The photo is from https://www.gelifesciences.com/en/ar/shop/protein-analysis/spr-
label-free-analysis/systems/biacore-t200-p-05644
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The field profile E¯0i and the propagation constant β˜i of mode i are de-
pendent on the light angular frequency ω, the geometry and the refractive
index n of all the materials (see Figure 1.5b).
Let us define the effective refractive index n˜e f f of the mode as:
β˜i =
2pi
λ
n˜e f f , (1.2)
where λ is the wavelength of the propagated light.
In addition, for the certain combination of these parameters, one can
achieve monomode waveguiding systems that have only one transverse
electric (TE) and transverse magnetic (TM) guided-wave.
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FIGURE 1.5: (a) Schematic of a slab waveguide. The total internal reflection
takes place in a waveguide when the nsubstrate< ncore >nclad condition is satis-
fied. The propagation direction is z. (b) The evanescent field penetrates into
the cladding layer, thus becoming sensible to environmental changes.
What is important for sensing is the fact that E¯0i (x,ω) is not to be strictly
confined to the core layer, but has exponentially decaying tails in the sur-
rounding materials as well, these are named the evanescent fields. The de-
cay length the evanescent field ranges from one tenth of the wavelength to
infinity, depending on the geometry and materials. Nevertheless, there is a
large interaction volume of the evanescent field with the surrounding mate-
rials. This is used in sensing, since each change in these materials is sensed
by the propagating optical modes and can be measured as a change in their
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characteristics. In most chemo-optical sensors the sensing action is localized
in the cladding region.
As the evanescent field of the guided mode penetrates into the cladding,
any refractive index change near to the waveguide surface yields a change of
the effective refractive index of the mode. This change is the basic of optical
waveguide based biosensors. Therefore, one of the properties of the biosen-
sor, such as the sensitivity, depends on the evanescent field. When used
as label-free sensors, the volume of interaction between the analyte and the
evanescent field can be very small, and mainly limited by the thickness of
the layer of the captured analyte. In the case of molecules of nanometric
sizes (like proteins), this means that most of the evanescent tail is unper-
turbed and does not contribute to the signal, thus the sensor will have a
small sensitivity. Simulations can evaluate the dependence of the sensitivity
from the thickness of the formed molecular layer [59].
Finally, what makes the use of waveguide based optical biosensors par-
ticularly interesting, is the possibility of their integration. In addition, there
is a large flexibility in the choice of construction materials and dimensions
for waveguides design. In particular, the systems based on silicon wafers
are small and robust, thanks to the development of silicon technologies in
the last few decades and the possibility of easy and economic fabrication of
Si, SiON and Si3N4 waveguides.
Different types of waveguide based optical biosensors differ on the way
the change in the effective refractive index of the propagating mode is mea-
sured. In the following sections, only the two geometries, i.e., interferome-
ters and microring resonators, studied in this thesis are described.
1.2.3.2.1 Interferometers
Waveguide interferometers have particular importance thanks to the smart
combination of two very sensitive methods, i.e., the waveguiding and the
interferometry techniques, which results in high sensitivity point-of-care
biosensors [60, 61]. Significant advantages of these techniques are the high
dynamic range and the long interaction length. Two of the most popular
types of interferometers for biosensing applications are Mach-Zehnder and
Young interferometers (YI). Both work on the same principle. A polarized
light beam of a coherent and monochromatic source is split into two beams
in the device, in order to propagate independently in the two arms of the
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interferometer. One of the arms, so called sensing arm, interacts with the
sample of interest, i.e., the target solution. The second arm serves as a ref-
erence, which either is insulated from the environment or interacts with a
reference sample. Any change of the target solution affects the effective in-
dex of the mode which, in turn, shifts the phase of the light propagating
through the sensing arm, compared to the one of the reference arm. The
different phases are measured by the interferometer.
The difference between the two kinds of interferometers is basically the
way how the interference of the two beams is recorded. In a Mach-Zehnder
interferometer (MZI), the beams are recombined in a waveguide which is in-
terfered to a photodetector, i.e., one output beam is observed. While in
a Young interferometers the light exists from the two arms and the inter-
ference is observed in the far-field. Figure 1.6 shows the basic design and
working principle of (a) MZI and (b) YI respectively.
Output beams
Photodetector
(a)
Output beams
Photodetector
(b)
FIGURE 1.6: Typical (a) Mach–Zehnder and (b) Young interferometer configu-
rations. The light coupled into the waveguide structure of the interferometer
is split into two beams, which propagate along the sensing and reference arms,
respectively. In the case of a MZI, the two beams are recombined by directing
them to the same waveguide, resulting in their interference. While the beams
of a YI are projected from two closely spaced outputs onto a detector array,
where an interference pattern is detected.
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Moreover, for increasing the sensing properties of MZI sensors, a config-
uration based on an asymmetry between interferometer arms is proposed
(aMZI) [62].
For the first time, in 1993 Heideman et al. [63] demonstrated a biosensing
platform based on integrated MZI. MZI were fabricated on a silicon sub-
strate with a Si3N4 waveguide and etched gratings for input/output cou-
pling. Biosensor, immobilized with antibodies, successfully detected human
chorionic gonadotropin (hCG). Since then many works have been reported
on integrated MZI biosensors [64, 65]. Parallel to integrated MZI, the de-
velopment of integrated YI was realized. The first demonstration of an in-
tegrated YI for sensing was done by Brandenburg and Henninger in 1994
[66]. After that many research papers on YI sensors implementation [67, 68]
have been published (see Table 1.2).
1.2.3.2.2 Whispering Gallery Mode Resonators
The Whispering Gallery Modes (WGMs) effect in dielectric optics has been
investigated since the 1960s [69], however the use of a small WGM resonator
for biosensing applications made its first appearance only in recent years
[70, 71]. When the light propagates along the closed loop of a waveguide
shaped in a ring geometry (named ring resonator), a self-interference takes
place, and if the interference is constructive, the field builds up in the cav-
ity. The eigenmodes that satisfy the constructive interference condition are
called WGM resonances. The wavelengths of the WGM resonances depend
on the geometry of the waveguide and of the ring, as well as, by the ef-
fective index of the circulating optical modes. Moreover, it is important to
note, that WGM resonators are not only limited to the microring (MRR) ge-
ometry [72]. In fact, many other examples of WGM resonators exist made
as microdisks[73], spiderweb ring resonator [74], microspheres [75], micro-
toroides [76] etc. Figure 1.7 shows a few WGM resonator structures.
The WGM has an evanescent field at the resonator surface which senses
the binding of biomolecules. WGM resonator based biosensors are, arguably,
the most promising competitors to SPR biosensors. They are entirely made
with low-loss dielectrics, and for this reason their resonances are sharper
and more resolved than that of SPR. In addition, unlike the straight waveg-
uide, the effective light-analyte interaction length of a ring resonator sensor
22 Chapter 1. Introduction
is no longer determined by the sensor’s physical size, but rather by the num-
ber of revolutions of the light supported by the resonator, which is described
by the resonator quality factor (Q-factor). Q-factor can be defined as the ra-
tio of the light stored in the resonator to the light dissipated per cycle. Due
to high Q-factors (>106), small molecule (≈50 Da) detection has been exper-
imentally demonstrated. Different proteins, down to a single molecule level
[77], have been detected by different configurations with different Q-factors
ranging between 103 and 108. As an example, streptavidin detection has
been performed with microspheres [75]. Recently thrombin detection was
also carried out by microrings [50].
(a) (b) (c)
(d) (e)
20 mm
200 mm 50 mm
FIGURE 1.7: Various WGM resonator configurations9: (a) racetrack resonator
[72], (b) microdisks [73], (c) spiderweb ring resonator[74], (d) microsphere [75]
and (e) microtoroid [76].
The possibility of miniaturization down to few tens of micrometer in
diameter and an easy integrability with photonic waveguides allow the re-
alization of complex systems. Some commercial apparatus based on WGM
biosensors are appearing on the market, with up to 128 multiplexed sensing
9I personally thank Dr. Mher Ghulinyan and Prof. Andrea Armani for providing pictures
for Figure 1.7 (c) and (e), respectively
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sites (and no cross-talk) as in the case of the Maverick system, from Gena-
lyte10.
It is fair to underline the importance of integrated WGM resonators in
a wide range of applications, such as telecommunication [78, 79], quantum
information [80], nonlinear photonics [81, 82] etc., where they play the role
of the key component of the system.
Microdisks and microrings are the main configurations used in inte-
grated platforms thanks to the flexibility in terms of size and fabrication ma-
terials, even though they suffer from high losses due to the roughness of the
surfaces. The light coupling is realized by in-plane or vertically integrated
bus waveguides. In contrast to the mentioned configurations, microtoroids
and microspheres show an extremely high quality surface smoothness, but
they have the disadvantage of being bulky and difficult in integration.
1.2.3.3 Fiber based biosensors
Finally, to complete the overview of optical label-free biosensors, we must
mention optical fiber based sensors. Thanks to their small size, flexibility, me-
chanical robustness, mature fabrication techniques and their essential prop-
erty of light guiding with low losses, these photonic devices are excellent
candidates for remotely sensing or for in-vivo biosensing. Fiber Bragg grat-
ings (FBGs), while developed as a tool for the telecommunications, have
flourished as a versatile sensor with a wide breadth of applications. They are
currently the most popular among all fiber-based optical sensors for analyz-
ing load, strain, temperature, vibration, and refractive index [83]. Particular
attention has to be reserved to long-period gratings (LRG) sensors, that are
demonstrated to be easily manufactured and highly sensitive [84, 85]. The
use of LRG in biosensing started mainly in 2000s. In 2007, Chen et al. real-
ized a target DNA sequence detection in real time with an optical biosensor
based on a dual-peak long-period fiber grating [86]. Aside from gratings,
several other fiber-based technologies have been developed, taking advan-
tage of cost effectiveness and waveguiding capabilities of optical nanofibers.
Due to the small dimensions, nanofibers have a very large evanescent field
outside the fiber, thus altering measurements of high sensitivity to refractive
index changes. Optical structures like MZI [87], coils [88] or ring resonators
[89] have been implemented based on nanofibers.
10https://www.genalyte.com/
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FIGURE 1.8: Fiber based biosensing configurations: (a) FBG on an etched fiber
[90], (b) nanofiber loop [91], (c) Photonic crystal fiber based biosensor [92].
Finally, a new type of fibers are used to make hollow fiber biosensors.
This type of biosensors is based on a photonic crystal fiber (PCF), which
is a fiber with air holes in the cross-section [92]. Two main advantages of
this type of biosensors are the fact that air holes in the fiber can act as a
simple fluidic channel to deliver the biological samples and that the unique
light guiding mechanism of photonic crystal fiber ensures a strong light-
matter interaction because of the large light-sample overlap. The array of air
holes may hold a few nL/cm sample volumes, making them more desirable
tools for biomedical applications. In Figure 1.8 few examples of fiber based
biosensors are shown.
1.2.3.4 Comparison of optical biosensors
There are plenty of other techniques, both optical and non-optical, for tar-
get molecule detection, but the listed ones are perhaps the most common
and studied. In Table 1.2, we put together known optical characteristics of
some biosensors in terms of bulk sensing. For bulk sensing we consider the
sensor response to an overall change of the cladding material, i.e., when the
environmental change occurs near to the surface of the sensor. It is differ-
ent from the surface sensing which is considered only when the analyte is
sensed by the ligand immobilized on the sensor surface. It is clearly visible,
that the integrated interferometers or WGM resonators based devices are ex-
cellent candidates for a new generation of high sensitive biosensors which
came after SPR. While the former table shows the performance of sensors
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obtained from the bulk sensing measurements, for a complete understand-
ing of cons and pros of each device, Table 1.3 represents the specific analyte
detection limits for various biosensors. Later in this thesis we will compare
the state-of-art with our results on label-free biosensors based on integrated
SiON microring resonators (MRR) and Si3N4 asymmetric Mach-Zehnder In-
terferometers (aMZI).
TABLE 1.2: Comparison of sensing performances of few optical biosensors in
terms of bulk sensitivity (Sb) and bulk limit of detection (LODb) measured in
refractive index units (RIU).
Sensor platform LODb Sb Q-factor Reference
(RIU) (nm/RIU)
SPR 10−5 - 10−8 104 - [93, 94]
Long range SPR 9.7 ×10−8 3.2 ×104 - [95]
MZI 10−6 - 10−7 2×104 - [96]
YI 8.5×10−8 7.5×103 - [97]
SOI microring 10−4 - 10−7 70 104 [72]
SOI microdisk 5×10−4 26 3.3 ×104 [98]
Microsphere 3 ×10−7 30 5 ×106 [99]
Opto-fluidic ring 10−3 0.315 - [100]
FBG 7.2×10−6 404 - [101]
LPG-PCF 4.42×10−7 2260 - [102]
Nanofiber 10−7 700 - [88]
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TABLE 1.3: Detection limit of various optical biosensors in case of specific ana-
lyte sensing.
Sensor platform Analyte Size LOD Reference
kDa11 nM
SPR imaging β2-microglobulin 11.8 1 [103]
SPR ATP 0.5 0.48 [104]
MZI Streptavidin 52.8 19×10−5 [105]
MRR miRNA 7.2 10−3 [106]
FBG CR protein 0.025 398 [107] 12
1.3 Motivation to my thesis work
As previously mentioned, the most common and traditional techniques for
Aflatoxin M1 detection in milk and dairy products are HPLC and ELISA.
They appear to be adequate and well studied for detecting the lowest con-
centrations of AFM1 defined by the European Commission regulation (EC),
i.e., 50 ppt (50 pg/ml) and 25 ppt (25 pg/ml) for adults and infants, respec-
tively. However, these analytical methods require trained personnel and
laboratory environment. Moreover, they are time consuming and expen-
sive. This fact encouraged the development of a new, economic, fact and
user-friendly biosensing device, that can be run out of specialized labora-
tories. To this end, a FP7 European project called Symphony “integrated
SYsteM based on PHOtonic microresonators and microfluidic components
for rapid detectioN of toxins in milk and dairY products”, grant number
61058013 started in 2013. The project consortium has developed a desktop
system that incorporates sample preparation and the functions of a small
laboratory to detect even very low concentrations of AFM1 in milk (see Fig-
ure 1.9). The developed system brings the testing into the dairy.
111Da=1g/mol
12In the reference it is reported LOD = 0.01mgL−1. The conversation is done by following:
398 nM = 0.01 mgL−1/25.106g mol−1
13Project website: http://symphony-project.eu/
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The Description of work [108] of the project states that:
“The objective of the Symphony project is the development of a system for the detec-
tion of aflatoxin M1 in milk for the dairy industry. Symphony project will deliver
and test in real settings a smart heterogeneous integrated system by the integra-
tion of key enabling technologies such as micro-nano-bio-systems and photonics,
polymer-based technologies for low-cost microfluidics and Si-based photonic struc-
tures”.
Thus, the project aims at the realization of a complex system, where the
sensor has to satisfy the requirements, of being multiplexed, reusable and
suitable for the integration with the rest of the apparatus, together with
ultra-sensitive detection limits.
FIGURE 1.9: Milk passes a long way from the dairy farm to the consumer, un-
dergoing time consuming laboratory tests and monitoring. If AFM1 is detected
this way in the middle, milk and other products are eliminated. In order to pre-
vent such economical loss, SYMPHONY device is developed to be used directly
in farms.
The need for an integrated system, with cheap light sources and detec-
tors, motivated the choice of silicon-based CMOS-compatible materials, to
be operated at wavelengths in the VIS-NIR range (see Figure 1.10).
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FIGURE 1.10: SYMPHONY device key components.
In the introduction it is shown that the Silicon Photonics is arguably one
of the most promising technologies for developing highly integrated, minia-
turized and multiplexed biosensors. Moreover, the use of silicon nitride,
Si3N4, and silicon oxynitride, SiOxNy, extends the possible range of light
guiding and sensing to the visible spectrum. This enables the on-chip in-
tegration of silicon-based photodetectors and fast developing VCSELs as a
light source. The Nanoscience Laboratory of the University of Trento has
had already an experience on investigation of silicon-based waveguides for
labeled biosensors realization, operating in the visible range [109]. However
the used fluorescence method had many limitations due to the background
noise caused by the scattered light, mainly generated at the interfaces of
the reaction wells. Therefore, for the further development of a biosensing
platforms, resonant WGM cavities and asymmetric MZI (aMZI) were inves-
tigated as alternative approaches, which have the potential of being more
robust to intensity fluctuation and noise. At the same time, these devices
fulfill the required low detection limits.
Motivated by these considerations and requirements, this thesis is de-
voted to the development and experimental investigation of silicon WGM
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microring resonators and aMZI based label-free biosensors for AFM1 detec-
tion in real milk samples, as well as to the integration of the SYMPHONY
device. Moreover, in this thesis, I have studied protein- antibody specific
binding using a multi-MRR photonic chip. A comparable to commercially
available SPR [110] or photonic crystal microcavities [111] affinity biosensor
is investigated for biotinylated BSA - anti-biotin interaction studies.
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Theoretical background
This chapter is dedicated to the theoretical bases of the characteristics of the
label-free biosensors that have been investigated in this thesis. First, we will
give a definition of the main parameters of any biosensing device, i.e. sensi-
tivity and limit of detection, then the working principles of the transducers,
in particular microring resonators (MRR) and asymmetric Mach-Zehnder
interferometers (aMZI) are described. Finally, the chapter is concluded with
a brief introduction of the biomolecular binding kinetics, the ligand-analyte
interaction models, affinity and dissociation constant, as well as the kinetic
rate constants calculation methods.
2.1 Label-free biosensing principle
As previously anticipated, the objects of our studies are integrated MRR and
aMZI sensors, that are both from the waveguide based biosensor’s family.
They are both based on the effective refractive index variations taking place
near the sensing surface. The former device is based on the shift of the
WGMs resonance, while the latter one detects the phase changes in the re-
sulting interference pattern.
Let us start with the basic principles of label-free biosensing. For this
purpose, one needs light propagating in an optical waveguide, that guar-
antees an evanescent field out of the waveguide. A specific ligand needs
to be immobilized on the waveguide surface to detect the analytes. Fig-
ure 2.1a shows a waveguide coated with antibody as a ligand. The guided
light propagates with an effective refractive index ne f f . This is a weighted
average of the real indexes probed by the propagating optical modes which
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depend also on the materials bound on the surface. Usually, each biosens-
ing experiment starts with a buffer flow that passes on the waveguide sur-
face and defines an initial refractive index that is sensed by the evanescent
field. We have a constant nbu f f er refractive index at t0 when the analyte
molecules, accompanied with other biomolecules that can be found in the
original analyte solution, arrive to the sensing region of waveguide. These
new molecules in fact, are concentrated on the surface of the sensor, re-
placing pre-existing buffer molecules. This exchange of material produces
local variations in the refractive index. Hence, this variation is caused by
the material change, but not by the molecular interaction, the refractive in-
dex undergoes a bulk change as it is shown in Figure 2.1b. The evanescent
field, which decays exponentially in few tens or hundreds of nanometers,
is suited to sense this local perturbation, while being almost insensitive to
fluctuations far in the cladding. Note that, while designing a waveguide
sensor, one has to consider the sizes of ligand and analyte in order to over-
lap the evanescent field, otherwise no sensing can be performed effectively.
Next, the specific binding between the ligand and the analyte takes place.
This molecular interaction leads a particular refractive index variation that
is specific to the binding reaction (Figure 2.1c). When the index of refraction
does not experience anymore variation, i.e., all the binding events have oc-
curred or the surface is saturated, the rinsing and/or the regeneration of the
sensor has to be performed. Special solutions particularly chosen for each
ligand and analyte are used for this purpose. During the rinsing process all
target and non-specific molecules are washed out and the buffer solution is
left to flow over the sensing region of the waveguide. This yields a refractive
index variation with respect to the initial value. When the sensor regenera-
tion process is completed, not always a complete regeneration of the sensor
can be carried out. It can happen, that some molecules of analyte remain
attached to the ligands, thus causing a partial recovery of the baseline value
of the refractive index (Figure 2.1d). If the sensor reused, this residual signal
has to be taken in account during the measurements.
Hence, the optical transducers studied in this thesis are specifically de-
signed to detect the phase shift of the guided light due to the binding of the
analyte. This can be accomplished by performing interferometric measure-
ments or by monitoring the spectral shifts of WGM resonances.
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FIGURE 2.1: Schematic drawing of the label-free biosensing approach, when
the waveguide is immobilized with ligand, in this case with antibodies: (a) the
evanescent field defines a baseline value of the refractive index when the buffer
is only present, (b) the bulk variation of the refractive index due to the environ-
ment changes near to the waveguide sensing surface, (c) the evanescent field
interacting with the captured molecules. The presence of the analyte perturbs
locally the refractive index, (d) the rinsing process of the sensor is taking place,
thus forcing the refractive index to return to the initial value.
2.1.1 Sensor characteristics
In order to give a preference to one or another sensing mechanism, the com-
parison between biosensing characteristics needs to be performed. Previ-
ously, in Table 1.2 we introduced a bulk Sensitivity (Sb) and Limit of Detec-
tion (LOD) of the sensors. These are parameters that are used in this thesis
for characterizing MRR and aMZI biosensors. Sensitivity quantifies the sen-
sor’s output signal produced by a unitary variation at the input. It is defined
as the ratio of the output signal variation to the refractive index variation ns
of the cladding. The measured output variable in the case of MRRs is the
resonance wavelength, λ0, of an optical resonator [112]. Here, the sensitiv-
ity in bulk sensing is given by:
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Sb,WGM =
∂λ0
∂ns
(2.1)
For the interferometers the measured quantity is the phase φ0 of the in-
terferometric pattern. Therefore, the sensitivity for aMZIs is defined as:
Sb,aMZI =
∂φ0
∂ns
. (2.2)
In the next sections we will show, that these sensitivities are propor-
tional, through geometrical factors, to the intrinsic sensitivity, which is de-
fined as:
Sb,i =
∂ne f f
∂ns
. (2.3)
The minimum amount of input that can be distinguished with a certain
confidence level is defined to be the Limit of Detection (LOD) of the biosen-
sor. It is the smallest signal that can be differenced from the background
(baseline) noise. According to the general accepted rule the signal must be
at least three times greater than the background noise [113].
When performing biosensing measurements, however, we are more in-
terested in the concentration of the target molecules (analyte) in the so called
solvent or buffer solutions. We can therefore distinguish between the mea-
surement limit of detection and the analyte concentration limit of detection
(LODa).
One method for the background noise calculation is to calculate the mean
and standard deviation of multiple readings of the signal in the absence of
any analyte, i.e. a signal given by the buffer (blank) solution. According to
the rules of statistical analyses, at least 20 readings of the blank have to be
performed, but in real experimental conditions it is not always practical to
perform multiple blank determinations. In this case, LOD can be extracted
from the sensor calibration curve by a regression line, i.e., by the depen-
dence of the signal from an analyte concentration. Here, the analytes are
the molecules different from the buffer. Hence the slope of the calibration
curve corresponds to the sensitivity of the sensor Sb,i, thus the LODa can be
calculated as:
LODa =
kσ
Sb
, (2.4)
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where σ is the standard deviation of repeated measurements of blank solu-
tions. On the other hand, the definition of the instrument LODi in terms of
the standard error of the regression is:
LODi = kσ+ a , (2.5)
where a is the intercept of the calibration curve.
The International Union of Pure and Applied Chemistry (IUPAC) rec-
ommends the use of k=3, which sets the confidence level to 99,7%.
The LOD therefore carries the influence of instrumental uncertainties,
which can arise in any component of the whole sensing system: signal read-
out unit configuration and detector dark signal, temperature and fluid con-
trol, purity of carrier buffers and analyte, laser source, etc. For this reason,
the fair comparison of the biosensors can be done considering the Figure Of
Merit (FOM) which depends only on the characteristics of the transducer
[114]. For WGM sensors with quality factor Q and a spectral full-width at
half-maximum δλ , we can define as:
FOM =
QSb,WGM
λ0
. (2.6)
In some works, authors prefer the use of the “intrinsic LOD”, ILOD [98],
defined as ILOD = FOM−1. This definition of FOM is also used for SPR or
photonic crystal cavity sensors [115]. This parameter for a comparison of
the intrinsic performances between (bio-)sensors can be used.
2.1.2 WGM microring resonators
There is a plethora of different designs based on WGMs for biosensing ap-
plications. In § 1.2.3.2.2 it was already presented the variety of biosensors
both integrated and free space, where the light propagates inside a close
loop. Among all configurations, microrings (MRRs) and microdisks are the
most convenient for integrated lab-on-a-chip devices being a versatile tool
for Silicon Photonics. MRRs depict a ring-shape bent single-mode waveg-
uide, closed on itself. If the waveguide is widened towards the center of the
ring, it eventually forms a microdisks, supporting a multi-modal propaga-
tion. The modes with grabbing light near the outer edges of the structure
will be confined by total internal reflection, and will circulate in a similar
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fashion to that of the microring. Thus, we can use a comprehensive model
for describing both structures at once [116].
Here we will discuss the simplest coupling mechanism, i.e., light point
coupling from the straight waveguide to the ring-shape waveguide (micror-
ing resonator) of inner radius R as it is presented in Figure 2.2.
Coupling
A1
A2
B2
B1
A1
A2B2
B1
t
-k*
t*
k
FIGURE 2.2: Schematics of the WGM ring resonator. The field amplitudes in
the waveguide and ring are labelled with A and B, respectively. The subscripts
label the positions before (1) and after (2) the coupling zone. The field trans-
mission and coupling coefficients are labelled t and k, respectively. The prop-
agation constant inside the ring is β and the radius of the ring is R. Losses are
defined by the α coefficient.
The field amplitudes in the waveguide and in the ring are A and B, cor-
respondingly, and the numbering 1 and 2 indicate the amplitudes before
and after the coupling zone. The propagation constant along the ring is β,
while the field transmission and coupling coefficients are labelled with t and
k, respectively, and the ∗ denotes their conjugated complex values. Light
propagation inside the ring is affected by losses of different origins. They
are categorized as:
• Absorption losses, led by the light-matter interaction. In the cladding
layer, the absorption of the evanescent field takes place. Both band-
to-band or free carrier absorption contribute depending on the wave-
length of the light.
• Radiative losses, take place due to the finite confinement of the optical
mode.
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• Scattering losses, due to the roughness on the exterior sidewall of the
resonator waveguide. This surface scattering is accentuated in bends
because the mode is pushed towards the sidewall of the waveguide.
All these losses can be described by a single parameter, named attenua-
tion coefficient α =∑iαi, where i means the contributions of surface and bulk
absorption, radiation and surface scattering.
In the following, another source of losses related to the coupling will be
described. Taking into account these facts, the coupling between the waveg-
uide and the microring resonator can be described by a matrix relation [117]:(
A2
B2
)
=
(
t k
−k∗ t∗
)(
A1
B1
)
, (2.7)
with
|t|2 + |k|2 = 1 . (2.8)
From the relation 2.8 the field amplitudes before and after the coupling
can be described by: 
A2 = tA1 + kB1
B2 = −k∗A1 + t∗B1
B1 = e−αpiRei2piRβB2 = aeiθB2,
(2.9)
where a = e−αpiR and θ = 2piRβ.
A2/A1 gives the waveguide transmission:
A2
A1
=
te−iθ − a
e−iθ − at∗ . (2.10)
Consequently, we can calculate the waveguide transmission coefficient
T as:
T =
∣∣∣A2
A1
∣∣∣2 = |t|2 + a2 − 2a|t|cos(θ + φt)
1+ |t|2a2 − 2a|t|cos(θ + φt) . (2.11)
where φt is the argument of the complex transmission coefficient t.
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Next, the solution of the system for the fraction of the B1 field coupled
into the microring resonator and the input field A1 is:
B1
A1
=
−ak∗
e−iθ − at∗ , (2.12)
which allows obtaining the microring cavity intensity build-up I:
I =
∣∣∣ B1
A1
∣∣∣2 = a2(1− |t|2)
1+ |t|2a2 − 2a|t|cos(θ + φt) . (2.13)
One can notice, that both, Eq. (2.11) and Eq. (2.13), are periodic in θ, with
a 2pi periodicity. Moreover, the microring cavity gets its maximum intensity,
i.e., resonates when cos(θ + φt) = 1 or equivalent by:
θ + φt = 2pim , (2.14)
where m is an integer number, called the azimuthal mode number. Often
φt is neglected in comparison to θ, since for microrings or microdisks R »
β−1, thus leading θ » φt and taking θ ≈ 2pi m. Indeed φt plays a role of a
corrector of the resonance spectral position near its intrinsic position. The
intrinsic spectral resonance condition can therefore be expressed as:
λm =
2piR
m
ne f f , (2.15)
where ne f f is the effective refractive index of the resonator mode. It is im-
portant to mention, that the exact calculation of ne f f is not trivial. It depends
on the wavelength and on the geometrical details of the resonator and can
be calculated both analytically or modelling. Considering known ne f f , the
transmission spectrum can be easily simulated by using Eq. (2.12). An ex-
ample of a simulated transmission spectrum is reported in Figure 2.3a.
38 Chapter 2. Theoretical background
8 4 7 8 4 8 8 4 9 8 5 0 8 5 1 8 5 2 8 5 30 . 0
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
F S R
 
Tra
nsm
issi
on
W a v e l e n g t h  ( n m )
F W H M
(a)
8 4 9 . 4 8 4 9 . 5 8 4 9 . 6 8 4 9 . 7 8 4 9 . 8 8 4 9 . 90 . 0
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
 C r i t i c a l  c o u p l i n g O v e r  c o u p l i n g U n d e r  c o u p l i n g n e f f  v a r i a t i o n 
 
Tra
nsm
issi
on
W a v e l e n g t h  ( n m )
Q = 2 3 K
Q = 2 7 K
Q = 9 K
(b)
FIGURE 2.3: (a) Simulated spectrum of a critical-coupled WGM resonator. (b)
Comparison of the resonance of WGM resonator when, respectively, a critical
(Q=23K), over (Q=9K) and under (Q=27K) coupling takes place. In addition,
pink line shows the resonance shift due to a ne f f refractive index variation.
In the transmission dips are periodically appearing due to the resonant
coupling with the microring resonator. The periodicity, i.e., the spacing be-
tween neighbor resonance deeps, is called Free Spectral Range (FSR), and
can be calculated from Eq. (2.15) as:
FSR ≈ λ
2
2piRng
, (2.16)
where ng is the group index:
ng = ne f f − λ
∂ne f f
∂λ
, . (2.17)
The Extinction Ratio (ER) that described the efficiency of the transmis-
sion, can be obtained by the value of the transmission at resonance:
ER−1 = T(λm) =
(a− |t|)2
(1− a|t|)2 . (2.18)
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Therefore, when |t| = a, ER becomes infinite and the transmission van-
ishes. This means, that all the input light is coupled to the microring res-
onator. This condition is named critical coupling and when it is satisfied the
light in the cavity interferes perfectly and destructively with the light trans-
mitted in the waveguide, causing drops to zero in the transmission. How-
ever, there are two other cases, i.e. over-coupled (|t| < a) and under-coupled
(|t| > a) regimes, where the resonance takes place, but the transmission does
not vanish. All three possibilities are shown in Figure 2.3b.
Next, the Quality factor Q of a resonance is defined as the ratio of the
energy stored in the resonator to the energy consumed per cycle by damping
processes, consequently it is connected with resonator losses. The losses
define the finite width of the resonances as well. Thus, we can define the
Q-factor as:
Q =
λ0
∆λFWHM
. (2.19)
Note that, in comparison with the critical coupling case, the Q-factor is
lower for over-coupling and higher for under-coupling regimes.
The measured value of the Q-factor can be expressed as [118]:
Q−1l = Q
−1
c + Q
−1
0 , (2.20)
where Ql is the loaded (measured) quality factor, Q0 is the intrinsic quality
factor, given by the losses of cavity (radiation, surface scattering, absorp-
tion), and Qc is the contribution of the coupling. In the same work, i.e.,
[118], the authors calculated the coupling Q-factor, considering the results
by Spillane et al. [119]. For Qc they got:
Q−1c =
2Q−1l
1−√Tmin
, (2.21)
where Tmin is the minimum of the measured transmission spectra at the res-
onance. In critical coupling, Tmin=0, thus Qc = 2Ql and Ql = 12 Q0. Finally, the
relationship between intrinsic Q-factor and the attenuation coefficient α is:
Q0 =
2ping
λα
. (2.22)
In the following discussions we will use Eq. (2.19) to measure the Q-
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factor. Finally, for the MRR based biosensors the sensitivity and the limit of
detection given by Eq. (2.1) and Eq. (2.4), respectively, will be used.
2.1.3 Mach-Zehnder interferometers
The second device, that has been studied in this thesis is asymmetric Mach-
Zehnder interferometer (aMZI). First, we will discuss in general MZI, then
will show the advantages of the asymmetric configuration. If in the case of
WGM resonators we deal with self-interfering light in a ring-shape closed
loop, here the interference happens by dividing and recombining light. A
schematic representation of such configuration is shown in Figure 2.4.
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FIGURE 2.4: Schematic of a Mach-Zehnder Interferometer in a biosensor con-
figuration. The splitted light amplitudes in the two arms are labelled with A
and B, respectively. The effective refractive indexes, ne f f ;A/B, are different in
the two waveguides, leading to different propagation constants. The interac-
tion lengths on both arms are, respectively, LA and LB.
A beam splitter located immediately after the input waveguide splits the
light beam into two parts, which propagate along two waveguides forming
an interferometer arms. After crossing the arms, the two beams are recom-
bined by a second beam splitter. The measured variable in this system is the
transmitted intensity which is strongly dependent on the relative phase of
the two beams at the second beam splitter. Here, LA and LB are called inter-
action lengths, the propagation constants and effective refractive indexes are
labelled as βA/B and ne f f ;A/B, for sensing and reference arms, respectively.
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The Mach-Zehnder is a favored configuration among interferometric de-
vices particularly for biosensing purposes, thanks to an easy accessible ref-
erence arm that minimized external variations, such as temperature change
or mechanical vibrations [63].
The sensing principle, as for any other waveguide based biosensor, is
based on evanescent field interaction with the material near to the waveg-
uide surface, in the sensing arm of MZI, leading to an effective refractive
index changes. The latter affects the phase difference. The phase difference
is then:
φAB = φA − φB = βALA − βBLB =
=
2pi
λ
(ne f f ,ALA − ne f f ,BLB) .
(2.23)
Considering the light recombination on the second beam splitter loss-
less, then the interference of the light leads to a transmission:
T =
1
2
[1+ cos(φAB)] . (2.24)
In biosensors based on interferometric devices, the detection of the phase
shift is realized by monitoring the transmission spectrum at a certain fixed
wavelength (see Figure 2.5).
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FIGURE 2.5: Transmission spectra of a MZI (black line). The red line shows the
transmission spectra shift due to a ne f f refractive index variation.
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The spacing between adjacent peaks of the MZI intensity response is
called Free Spectral Range (FSR).
If we assume that the arm A is exposed to a sensing liquid and the arm
B is protected by a cladding layer, an estimate of the bulk sensitivity we can
be obtained the:
Sb =
∂T
∂nA
= − sin(φAB)
2
∂φAB
∂nA
= −piLAsin(φAB)
λ
∂ne f f ,A
∂nA
. (2.25)
The sensitivity of a MZI can be optimized by increasing the LA interac-
tion length.
When the two arms of the interferometer have the same effective refrac-
tive index and optical path length, so called balanced MZI, it is hard to de-
tect a phase variation. Therefore, it is better to use other MZI geometries
which optimize the sensitivity.
2.1.4 Asymmetric Mach-Zehnder interferometers
To achieve a high sensitivity, one way is to artificially increase the phase
difference. This is done in an asymmetric design of MZI (aMZI). aMZI con-
sists of inequivalent, i.e., unbalanced arms as a result of the removal of the
cladding and of an additional path length introduced in only one of the arms
[62]. An additional path length can be added to the reference arm, as well
as the width of the waveguides in the sensing and reference arms can be de-
signed differently [120]. Each of these techniques contributes in increasing
of the sensitivity by affecting the phase delay. The efficiency of the configu-
ration will be maximized if both these contributions converge together, thus
ensuring the transmission at the output port being wavelength-dependent.
Figure 2.6 represents an aMZI configuration.
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FIGURE 2.6: Schematic of an asymmetric Mach-Zehnder Interferometer in a
biosensor configuration. The sensing window is present only on the upper arm
of aMZI, while the second arm has an additional length. The interaction lengths
on both arms are, respectively, LA and LB.
If we assume that the wavelength scan is performed in a small range
(δλ) starting from a given wavelength (λ0), then the phase difference accu-
mulated by the light during the propagation in the two arms (φAB(λ)) is:
φAB(λ) = φAB(λ0 + δλ) ≈ 2pi
λ0
(ne f f ,ALA − ne f f ,BLB)(1− δλλ0 ) =
φ0 − 2piδλ
λ20
(ne f f ,ALA − ne f f ,BLB) ,
(2.26)
where
φ0 =
2pi
λ0
(ne f f ,ALA − ne f f B, LB) , (2.27)
By defining Λ = λ02/(ne f f ,ALA-ne f f ,BLB), we can straightforwardly compute
the transmission spectrum of the aMZI as:
T(λ0 + δλ) ∼= 12 [1+ cos(φ0 −
2piδλ
Λ
)] . (2.28)
Λ defined by this way, plays the role of the FSR [121]. In order to make
Λ arbitrarily short one can increase the optical path difference between the
two arms. Reducing the FSR, the steepness of the curves of the transmission
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spectrum and the number of visible peaks (and valleys) in a given wave-
length range increase. Therefore, Λ sets the intrinsic resolution for the mea-
surement of the phase φAB(λ).
φAB(λ) is measured via a sinusoidal fit of the transmission spectrum,
and, from its variation, changes in the refractive index nA are measured
once other parameters are known. The bulk sensitivity (Sb) is computed as:
Sb =
∂T
∂nA
∼= ∂φ0
∂nA
=
2piLA
λ0
∂ne f f ,A
∂nA
, (2.29)
Moreover, Sb is independent from the actual φ0 value, thus giving the
possibility to increase Sb by choosing a longer LA. In addition, in the design
of the aMZI we can construct waveguides of any shape, i.e., straight, curved
or spiral, thus increasing the sensing area and the resolution of the sensor.
However, there is always a limit for the device dimensions, since the ab-
solute intensity and the visibility of the interference fringes depend on the
propagation loses which increase if the aMZI arms are too long. Hence, the
ultimate LOD of the system is highly depending on the operation points of
the device, i.e., the total interaction length and the sensitivity of the system,
as well as the perturbations due to the liquid non-homogeneous distribution
in the large sensing area.
2.2 Binding kinetics
The last section of this chapter is dedicated to the molecular binding models
and to the introduction of binding characteristics of a biosensor, like affinity,
dissociation constant, association and dissociation rate constants.
Label-free affinity biosensors are widely used for monitoring and ana-
lyzing the biospecific interaction between immobilized ligand and dissolved
analyte. The characterization of antibody affinity and kinetic studies of
antibody-antigen reactions are needed to select the appropriate reagents for
immunoassay. Hence, kinetic analysis are performed to characterize the re-
versible, non-covalent binding in terms of binding strength and speed. As
any binding mechanism, non-covalent binding is affected by several contri-
butions, such as hydrogen bonds, ionic/electrostatic interactions, van der
Waals forces, and finally hydrophobic effects [122].
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Let us to describe the steps of the recognition reactions. Once the ligand
is immobilized on the surface for the selective binding of its antigen, i.e.,
analyte, the specific recognition and binding is supposed to occur. Each re-
action consists of two phases, i.e. association and dissociation, where the
former shows how fast one molecule binds to another by forming com-
plexes, and the latter points to the speed of the complex destruction. If the
biomolecular system is left to incubate for a certain time, it will reach en
equilibrium and the rate of complex formation and destruction will be the
same. Thus the number of bound and unbound molecules will be constant.
Dissociation phase depends on the complex strength, that is conditioned
by the binding affinity, giving an information on the complex formation in
equilibrium.
The binding depends on the dimensions of the reacting molecules, as
well as on the presence of disturbing non-specific molecules, thermal in-
fluence, etc. The influence of non-specific binding can, in fact, disturb a
measurement, giving a fake information about signal levels, causing incor-
rect estimation of affinity constant. When the functionalization of the sensor,
i.e., ligand immobilization, is performed, the process is realized to minimize
non-specific interactions.
Finally, the molecular binding events are followed by the sensorgrams,
which refers to the time dependence of the signal shift (resonance wave-
length, phase, angle, etc.). The characteristics of the molecular reactions can
be extracted from the fit of the sensorgrams. Several models exist to de-
scribe the molecular system. Therefore, here we will briefly discuss three of
them, i.e., 1:1, heterogeneous and mass transport. Note, that the molecular
interaction studies presented in this thesis are based on the 1:1 model only.
2.2.1 1:1 Binding model
Let us describe the mechanism of getting an information about the molecu-
lar interactions from the effective refractive index changes near to the sensor
surface.
At a given time, the sensor response R, which is the resonance shift in
case of MRRs or the phase shift for aMZI, can be approximated by the sum
of four contributions:
R = RR + RL + RA + Rns , (2.30)
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where RR is caused by the refractive index of the sample buffer, RL due
to refractive index change caused by immobilized ligand, RA due to analyte
bound to immobilized ligand and Rns due to nonspecific binding. Therefore,
the rate of change of R is:
dR
dt
=
dRR
dt
+
dRL
dt
+
dRA
dt
+
dRns
dt
. (2.31)
Since the composition of the buffer solution is constant during the ex-
periment, then dRR/dt=0. Moreover, the ligand is anchored at the sensor
surface by the covalent bonds or by the disulfide bonds, no ligand leakage
is assumed to take place, thus dRL/dt=0. And, finally, we consider that
the ligands are specific to the target molecules and no non-specific binding
events occur, therefore dRns/dt=0. Under these hypothesis, the sensorgram
shows only the sensor response due to the analyte binding. Thus:
dR
dt
∼ dRA
dt
. (2.32)
Let us suppose that the ligand L and the target molecule A bind re-
versibly in solution to form a binary complex AL. Here, we will discuss
the case when the L ligand has only one single binding site. This binding
model represents a simple 1:1 interaction.
L + A
kon−−⇀↽−
ko f f
LA , (2.33)
where kon is the second-order rate constant for complex association and
ko f f is the first-order rate constant for complex dissociation. The rate of
complex formation depends on the free concentration of A and L ([A] and
[L] correspondingly) and on the stability of the complex:
d[AL]
dt
= kon[A][L]− ko f f [AL] . (2.34)
Therefore, the concentration of complex [AL] is identical to the concen-
tration of bound analyte and, consequently, is proportional to the response
RA. The free ligand concentration [L] is the difference between the total
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and the bound ligand concentrations. The maximum response due to ana-
lyte binding, Rmax will therefore be proportional to the total ligand concen-
tration and (Rmax-RA) will be proportional to the free ligand concentration.
The free concentration of the analyte continuously flowing over the sensor
may be considered constant and identical to the total analyte concentration,
C. With these assumptions Equation (2.34) can be written in the following
form:
dRA
dt
= konC(Rmax − RA)− ko f f RA =
= konCRmax − (konC + ko f f )RA .
(2.35)
The system reaches an equilibrium after leaving for a long time. Eventually
the binding interaction reaches a point where association and dissociation
rates compensate each other. At this point the level of signal reaches a con-
stant value RA = Req. Thus, the association equation can be written as:
dRA
dt
= konCRmax − (konC + ko f f )Req = 0 . (2.36)
The solution of the differential Eq. (2.35) with the boundary condition 2.36
is:
RA(t) =
konC
konC + ko f f
Rmax[1− exp(−(konC + ko f f )t)] =
= Req[1− exp(−(konC + ko f f )t)] .
(2.37)
Introducing a new parameter:
kobs = konC + ko f f , (2.38)
the Eq. (2.37) can be rewritten as:
RA(t) = Req[1− exp(−kobst)] , (2.39)
where Req is the response at equilibrium and kobs is the experimentally
determined value of the pseudo-first-order rate constant for approach to
equilibrium. By fitting the sensor response with Eq. (2.39), we can extract
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the values for Req and kobs. Doing the same for different analyte concen-
trations it is possible to obtain a linear dependence for kobs values on the C
concentration. The linear fit of this dependence should then yields a slope
equal to kon and an intercept equal to ko f f .
The equilibrium dissociation constant for the complex is defined as the
ratio of ko f f and kon:
KD =
ko f f
kon
. (2.40)
The affinity KA of analyte molecules is inversely proportional to the KD
value.
Sometimes this method for KD calculation yields significant uncertain-
ties due to the exponential fit. Therefore a different approach can be used for
the equilibrium analyses, based on Langmuir isotherm [49, 123]. For differ-
ent concentrations C of the analyte the measured response RA is described
by:
RA =
Rmax
(1+ KDC )
. (2.41)
The values of KD and Rmax can be determined by fitting RA as a function of
C concentration with Eq. (2.41).
Note, that equilibrium and saturation are different phases. The relation-
ship between Req and Rmax is in direct dependence to the analyte concentra-
tion C relative to KD. For instance, if we take a C = KD, we will get Req =
0.5 Rmax, i.e., 50% of possible maximum signal. Normally, Rmax is generally
observed, if C > 10KD condition is satisfied.
Finally, in the dissociation phase, the analyte concentration is suddenly
reduced [A]=0 by injecting the running buffer. The response of the sensor
follows an exponential decay. Hence, no complex formation takes place in
this phase, from the Eq. (2.34) we will get:
d[AL]
dt
= −ko f f [AL] = 0 , (2.42)
which yields to:
d[RA]
dt
= −ko f f RA(t) . (2.43)
Considering the fact, that the dissociation starts from the Req signal level,
the solution of the differential equation 2.43 is:
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RA(t) = Reqexp(−ko f f t) . (2.44)
Figure 2.7 shows a typical sensorgram starting with a baseline, corre-
sponding to buffer, i.e., analyte is missing, then an analyte is inserted and an
association follows there, the signal increases according to Eq. (2.39). Next,
an equilibrium is achieved and the signal remains stable. Then the analyte
is removed and the buffer is flown again. This last part of the sensorgram
corresponds to the dissociation described by the Eq. (2.44).
Buffer
Equilibrium
time (s)
R 
Req
𝑹𝑨 𝐭 = 𝑹𝒆𝒒 = 𝐜𝐨𝐧𝐬𝐭
FIGURE 2.7: Example of a sensorgram showing an initial baseline, where the
analyte is missing, an increase of the signal due to the association phase, an
equilibrium, corresponding to the constant signal and, finally, a decrease of the
signal during dissociation.
2.2.2 Heterogeneous Binding model
The 1:1 model is an ideal case and not always suites for more complex sys-
tems. Let us introduce the 2:1 heterogeneous ligand model, that assumes a
single analyte binding at two independent ligand sites simultaneously. Each
ligand site binds the analyte independently with a different rate constant. In
this case the reactions will be the followings:
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
L1 + A
kon1−−⇀↽−
ko f f 1
L1A
L2 + A
kon2−−⇀↽−
ko f f 2
L2A ,
(2.45)
where, as before, A is the analyte and L represents the immobilized lig-
and. This molecular behavior is typical for small dimension ligands and,
respectively, big analytes. Alternatively it can describe the case when the
ligands are too dense on the surface and some overlap happen. Since each
ligand react with only one analyte, this model can be assumed as a combi-
nation of two 1:1 models. The fit function will be the same of two Eq. (2.39),
adding a parameter to account for the percentage of the binding contributed
by each interaction. This model is useful if we record a sensorgram with an
association phase, which shows an initial fast on-rate followed by a slower
on-rate. This will cause a signal continuous increase, rather than an equilib-
rium. While in the dissociation phase, an initial fast dissociation is followed
by a slower off-rate, with the higher concentration curves that do not permit
to recover baseline as it is represented in Figure 2.8 with the red line.
Buffer
time (s)
R 
FIGURE 2.8: Examples of sensorgrams for the heterogeneous (red) binding and
mass transport (blue). Heterogeneous binding is characterized by biphasic
curves that do not reach equilibrium and often do not return to baseline sig-
nal in the dissociation. Mass transport limited curves are usually represented
by straight lines.
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2.2.3 Mass Transport model
We conclude this section with the description of the mass transport model
which can be applicable when the analyte molecules flow over the biosensor
surface via laminar flow. Hence, the frictional forces from the sides of the
tubing and the surface of the biosensor slow the velocity of the liquid close
to the surface. This decreases the flow rate on the sensor site, distracting
efficient exchange of analyte molecules from the surface to the bulk solu-
tion. Here, the binding rates depend on the supply of analyte molecules
rather than the kinetics of biomolecular interactions. Moreover, at low con-
centrations, the binding between the ligand and the analyte molecules, near
the biosensor surface, can occur faster than the analyte replacement in the
surrounding solution. The shape of the binding curve is determined by
the analyte diffusion rate. It is clear, that flow rate plays a crucial role in
such systems. Basically, it adjusts the analyte molecules diffusion on the
sensor surface, consequently the binding kinetics. Mass transport model is
explained by the following expression:
Abulk
km−⇀↽−
km
Asur f + L
kon−−⇀↽−
ko f f
LA , (2.46)
Often mass transport limited curves appear as straight lines as it is shown
in Figure 2.8 with a blue line [122]. The model for mass transport limited
data analyses is built on two fundamental steps, i.e., the rate of analyte
transport from the bulk solution to the surface (km), and the interaction of
the analyte with the ligand. When km is much smaller than kon[A], then
the limitation caused by diffusion, can be significant. One way to reduce
the mass transport effect, is to increase the analyte concentration and to re-
duce the number of immobilized ligands. Increasing the flow rate also will
eliminate effects of the phenomenon.
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Experimental apparatus
The development of a biosensing system that is able to sense
• the smallest changes of the liquid environment near to the sensing sur-
face,
• the binding of biomolecules of few hundreds of Da molecular weight,
and that is able to give repeatable results is a complicated task. A part from
the sensor itself, there is a number of critical points to be considered:
• the stability of of intensity, polarization, wavelength and temperature
of the laser source,
• the mechanical stability of the light coupling system,
• the temperature stability of the sensor, sensing liquids as well as of the
environment,
• the alignment of the flow-cell with the sensor chip, insuring a homo-
geneous flow and the absence of leakage of flowing solutions,
• the minimization of electrical noise in the readout system,
• the reproducible and efficient coverage of the sensor (surface function-
alization) with the specific receptors, i.e. aptamers and antibodies.
During my PhD I worked with different biosensing devices demanding
different approaches for sensing measurements, that is why in this thesis,
different experimental setups have been implemented. In this chapter, all
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the different schemes used for the aMZI and MRR based biosensors devel-
opment are presented. Figure 3.1 shows a general setup of the experiments.
The main difference between setups is related to the chip design and, con-
sequently, to the coupling methods. Next we will present for each setup the
appropriate image.
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FIGURE 3.1: Schematics of the experimental setup.
3.1 Chip design
First, the design and characteristics for the sensor platforms that have been
used for AFM1 detection in buffer as well in milk solutions within the SYM-
PHONY project and for the anti-biotin sensing measurements will be pre-
sented. For the first, two sensors based on integrated microring resonators
and asymmetric Mach-Zehnder interferometers were designed and fabri-
cated. All sensing measurements were performed in UNITN, while anti-
biotin related experiments were performed in Lionix International on the
third sensor design. All the three chip designs consider the actual laser tun-
ing range to cover the range of at least two FSR-s.
54 Chapter 3. Experimental apparatus
3.1.1 Microring resonators for SYMPHONY
The first sensor configuration is the SYMPHONY sensor based on MRRs,
which was developed by D. Gandolfi and A. Samusenko. For the fabrica-
tion of the microring resonators, in FBK a Plasma-Enhanced Chemical Vapor
Deposition (PECVD)for SiOxNy deposition is used. SiOxNy is transparent at
850 nm. This material demonstrates several properties, that allow to vary re-
fractive index of the dielectric material between 1.45 (nSiO2) and 2 (nSi3 N4) by
changing the relative amount of nitrogen and oxygen atoms, that, from the
other hand, influences on the optical scattering and reduces losses, by relax-
ing the strain at the silica-SiON boundaries, while keeping a high refractive
index contrast with silica cladding. Deposition is realized on 6-inch 625 µm
thick c-Si wafers with a 4 µm thick buffer oxide layer. Fabricated SiON film
thicknesses are 305 nm and 350 nm respectively for BS2 and BS3 wafers,
with 1.66 refractive index. Both thickness values are measured after a ther-
mal treatment at 1050◦C. The SiON waveguide circuit, consisting of waveg-
uides, splitters and racetrack resonators with 100 µm radius, is realized with
UV-photoli-thography and reactive ion etching. Then, the SiON is covered
by a 1 µm thick cladding layer in silicon dioxide (SiO2). The sensor sites
are defined by opening a 20 µm-wide window on top of the ring resonators
using a combination of reactive ion etching and chemical etching. The gap
between the 1 µ-wide ring waveguide and 0.9 µ-wide bus waveguide in the
35 µm-long coupling region is 0.6 µm. The two different waveguide widths
are due to phase matching the modes in the coupling region. On the chip,
the signal from the input waveguide is coupled to four MRRs by directional
couplers. The design of the sensor is shown in Figure 3.2.
3.1. Chip design 55
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Lcp=35mm
R=100mm
Gap=0.6mm
Sensing window 
W=20mm
Output 1
Output 2
Output 4
Output 3
(a)
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FIGURE 3.2: (a) Sketch of the microring resonator chip, (b) SEM image of the
single MRR, (c) photograph of the chip and a one euro-cent coin for size com-
parison and a zoomed microscopic view of the chip illuminated with VCSEL.
A drop of water is added on the chip.
3.1.2 Microring resonators for anti-biotin sensing
The second design of MRR-based chips are realized and manufactured in
LioniX International BV by means of the TriPleX technology [124]. A 4
inches 525 µm thick silicon substrate is oxidized to form a 8 µm thick ther-
mal oxide layer. Then, a 103 nm thick LPCVD (low-pressure chemical va-
por deposition) Si3N4 layer (refractive index: 2.02) is deposited onto the
thermal oxide followed by a thin LPCVD SiO2 cladding layer. This layer
stack is patterned by using photolithography, dry etching (RIE) and, subse-
quently, resist removal. The waveguides were, then, covered with a further
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6 µm thick LPCVD SiO2 cladding. In order to enable interaction between
the waveguide evanescent field and the liquid sample of interest, the top
(SiO2) cladding is locally removed by opening the sensing windows. This
is accomplished by a photolithography step and BHF wet etch down to the
Si3N4 waveguide core layer. All chips fabricated in LioniX are designed in
a way to guarantee propagation losses below 0.1 dB/cm and in order to en-
sure bending losses below 0.01 dB/90◦ bending radii >100 µm are used. The
design of the sensor is shown in Figure 3.3.
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Reference MRR
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Drop port
R=100 µm
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Coupling length
L=50 mm
Gap 0.75 µm
Input port
FIGURE 3.3: Sketch of the microring resonator chip; (inset) Design of the single
MRR: it consists of a racetrack shaped microring with radius 100 µm, coupling
length 50 µm, gap 0.75 µm. Waveguide width is w=1.0 µm.
3.1.3 Asymmetric Mach-Zehnder Interferometer
Another sensor design for SYMPHONY project based on aMZI was realized
and fabricated by LioniX International BV based on the TriPlex technology
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[125]. The same fabrication process as it was described in the previous sec-
tion, has been used for multi-aMZI chips. A sketch of the sensor is reported
in Figure 3.4. Eight aMZI are integrated in a single chip. Four of them (up-
per part of the design) have opening windows on both arms, while the other
four aMZIs (bottom ones) have opening windows only on one arm thus in-
creasing the phase difference between the light on both arms. This makes
such device more sensible for environmental changes.
Output 3
Output 4
Output 2
Output 1
Input
DL=640 mm
Sensing arm
L=6.25 mm 
Sensing window S=640×660 mm² 
FIGURE 3.4: (left) Sketch of the asymmetric Mach-Zehnder Interferometer
based chip; (right)photograph of the chip and a one euro-cent coin for size
comparison. White square encloses the aMZIs on the chip that were used for
the measurements.
A same input signal is sent to the four aMZI by a one to four channel
splitter. The long optical path length of the sensing arms is L=6.25 mm,
and it is achieved by a spiral waveguide to minimize the footprint. The
difference in optical path-length determines the FSR of the aMZI and is cho-
sen such that it matched the bandwidth of the used Vertical-Cavity Surface-
Emitting Laser (VCSEL). Three out of the four aMZI have the sensing win-
dow on top of the sensing arm. Openings are shown in the Figure 3.4 by
blue hatched regions. The fourth aMZI is left covered by the cladding in
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order to isolate it from the microfluidic chamber and, therefore, to be used
as the reference sensor (baseline sensor). This aMZI is used as an internal
reference both for the input signal intensity (e.g. to control the VCSEL fluc-
tuations) and for temperature. The area of and pitch between the sensors are
chosen such that each individual sensor can be functionalized by a spotter
with a different chemistry allowing internal consistency tests or multiana-
lyte detection. Note that the input and output waveguides are all on the
same edge of the chip.
3.2 Optical setups
In this section the key components of the optical setups will be described.
3.2.1 VCSEL at 850 nm
For the all experiments, presented in this thesis a VCSEL diode laser is used.
In particular it is a VCSEL diode U-L-M Photonics ULM850-B2-PL-S0101U,
which is sold as bare-die, and can be bonded with a flip-chip method di-
rectly at the input of the waveguides. Moreover, these VCSEL diodes are
single mode, polarization maintaining and can be tuned in wavelength by
more than 1.6 nm, by changing the driving current. During the wavelength
tuning, the probability of experiencing a mode-hop is low, because the ver-
tical cavity is very short and, consequently, the FSR is large.
An optical setup based on fiber coupling was developed (see § 3.2.2),
where the VCSEL source was the same, but in a TO46 can, ULM850-B2- PL-
S46FZP that helps during pigtailing process for handling glue inside. The
pigtailing of the VCSEL diode was performed at UNITN. The output beam
from the laser diode is circular, and by aligning a single-mode optical fiber
(see Figure 3.5a), I was able to achieve almost 55 % optical fiber in butt-
coupling efficiency (the fiber Mode Field Diameter (MFD) was 5 µm). Once
the correct position of the fiber is found, a small drop of UV-curable glue
is placed on its tip. This curing of the glue is done with a UV-curing LED
system first with low powers (20 mW) for 30 seconds for couple of times in
order to avoid fast crystallization of glue that can cause fiber misalignment.
Once glue is hard and the fiber is stable, we use a high power (120 mW) illu-
mination for 5-6 minutes for final fixing the fiber in his position. To increase
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the mechanical stability of the bonding, an additional drop of epoxy glue is
put into the TO46 can, filling the empty volume. For better protection of the
fiber from bend tensions on the glued point, a short piece of shrinking tube
is wrapped around the assembly.
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FIGURE 3.5: (a) Microscope picture taken during the fiber pigtailing of the
VCSEL source. (b) Calibration of the lasing wavelength of the VCSEL, as
a function of the driving voltage. The wavelength has been measured with
an Optical Spectrum Analyzer (average uncertainty 5 pm), (c) ITC502 - Laser
Diode/Temperature Combi Controller, (d) TCLDM9 - TE-Cooled Mount.
From a commercial 2 mW laser diode, a maximum output power from
the pigtailed fiber of 1.1 mW was achieved. This way pigtailed VCSELs
output power is very stable in time that yields the stable alignment of the
fiber.
To drive the VCSEL, the current has to be in the range from 2 mA (lasing
threshold) to 6 mA (damaging threshold, output power 2 mW). This range is
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too small to be accurately tuned by most of the commercially available laser
drivers. In fact in NanoScience Laboratory we have a Laser Diode/Temperature
Combi Controller, but only the part of temperature controller was suitable
for our system. To overcome this problem, we connected the laser in series
with a resistor of R = 550 Ω, and we drove it directly by setting the voltage
with a function generator.
Figure 3.5b shows the calibration curves for the emission wavelength,
measured with an OSA, as a function of the driving voltage. We fit the data
with second and third order polynomial functions. One can see that even
the second order is sufficient. From the fitting coefficients in the sensing
experiments we extract the emission wavelength by measuring the driving
voltage.
In order to keep stable the laser temperature, we used a temperature
controller1 (see Figure 3.5c) connected to the laser diode mount2, both from
Thorlabs, showed in Figure 3.5d. Laser diodes can be quickly and easily
changed in the mount. It is as simple as inserting the laser diode into the
socket according to the imprinted pin assignment. The diode socket is lo-
cated very close to the front of the cold plate making the connection of short
lead devices easier.
3.2.2 Light coupling with fibers
In the beginning of this chapter we presented the schematics of the experi-
mental setup. The main difference while changing the chips, is the method
of light in/out coupling that leads the use of different apparatus. In all uti-
lized setups light was coupled into the photonic chip by optical fibers. Dur-
ing my PhD I used to work with two types of fiber "setups". First one was
based on a system of two single tapered fibers. On the second optical setup,
I used a fiber array that has a spacing between fibers equal to the distance
of the waveguides on the chips. Note, that the polarization of the light at
the input of a chip is controlled by using a 2-paddles polarization controller
placed between the VCSEL and the input fiber (See Figure 3.1).
1https://www.thorlabs.com/thorproduct.cfm?partnumber=ITC502
2https://www.thorlabs.com/thorproduct.cfm?partnumber=TCLDM9
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3.2.2.1 Light in/out coupling by tapered fibers
During the first year of SYMPHONY project, for preliminary tests a single
MRR on the chip is used. For this purpose, the optical fiber setup consisting
of two tapered lensed optical fibers, OZ-Optics TSMJ series are used, that
are positioned with sub-micrometric precision with a six axis remotely con-
trolled mounts on two XYZ-translation stages, Newport Ultralign 562 series
actuators, Newport NanoPZ PZA12 is used. The use of tapered lensed fibers
is highly recommended, as it reduces the insertion losses to the photonic
chip, by improving the matching of the mode field diameter. The use of the
remotely controlled actuators permits more precise fiber alignment thanks
to the range of motion and stability that ensures 30 nm of motion sensitiv-
ity with no loss of position when power is removed. The photonic chip is
placed on a flat holder.
1
1
2
4
3
5
FIGURE 3.6: Photograph of the experimental setup. In the photo the number-
ing corresponds to: (1) the translation stages for the precise alignment of the
optical fibers, (2) the remotely controlled Newport NanoPZ PZA12 stage, (3)
sample holder, (4) the home made microfluidic flow-cell fixed on the chip, (5)
the optical tapered lensed optical fiber.
The position of this holder can be translated longitudinally and verti-
cally with micrometric screws, Newport Ultralign 561D. To visualize the sam-
ple and the positioning of the fibers, an optical microscope is placed above
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the holder. The microfluidic flow-cell is fixed on the chip surface with small
screws that are screwed on the holder. Figure 3.6 shows described setup.
3.2.2.2 Light in/out coupling by fiber array
The schematic layout of the fiber array for coupling light from the VCSEL
to the chip and back to the photodetectors (PD) is shown in Figure 3.7. This
fiber array consists of thirteen fibers each 1 meter long (see Figure 3.8a).
Single mode (SM), multimode (MM) and single mode polarization main-
taining (PM) fibers are used for this array. The operating wavelength range
of the 780-HP SM fibers is 780-970 nm, with a core diameter of 4.4 µm, while
PM780-HP PM fibers have 770-1100 nm operating wavelength range and
correspondingly 4.5 µm core diameter. The GIF50C MM fiber has an operat-
ing wavelength range between 800-1600 nm and a core diameter of 50±2.5
µm. The fiber array facet is polished under an angle of 0◦. The distance be-
tween fibers is 250 µm which corresponds to the distances between neighbor
waveguides on the chip.
Pitch 250 mm
. . . . . . . . . . .
.
.
. 780-HP (SM) GIF50C (MM) PM780-HP (PM)
FIGURE 3.7: Fiber array used to couple light from the VCSEL and back to the
photodetectors. In red are the single mode output fibers, in blue a multimode
fiber and in green the single mode polarization maintaining input fibers used
for simplification of the alignment process.
Orientation of the slow and fast axis of the polarization maintained (PM)
fiber can be found in the same figure and in combination with the output of
the used laser results in TE mode coupling into the chip.
For MRR multi-channel experiments within SYMPHONY project, we
used a tapered lensed optical fiber for input and described fiber array for
output light coupling, since input and output waveguides are located on
the different edges of the chip, while for aMZI chips only a fiber array is
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enough for light in/out coupling since all the input and output waveguides
are on the same edge.
(a) (b)
FIGURE 3.8: (a) The picture of fiber array that consists of thirteen 1 meter long
fibers. (b) Zoomed view on the optical fiber array positioners and the chip
under the PDMS microfluidic flow-cell fasten on the chip holder.
The fiber array was positioned relatively to the chip thanks to the alu-
minum holder placed on XYZ-translastion stages, Newport Ultralign 562 se-
ries. In the Figure 3.8b it is shown a light coupling stage based on a fiber
array.
3.2.3 Alignment stage
Even though light coupling from the fiber array to a chip was done with
high stability, however chip replacement and realignment was a relatively
long process. For this reason, Lionix International built a miniaturized fiber
array to chip alignment stage (see Figure 3.9) devoted to handling our chips.
The input waveguide and the four output waveguides in the chip (see
Figure 3.4) are interfaced to a fiber array. The stage reliably and quickly
aligns and fastens the photonic chip to the fiber array and, at the same time,
provides the microfluidic circuits.
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FIGURE 3.9: 3D renderings of the miniaturized alignment stage: The chip is
placed into the insert of the holder and clamped into the corner by the handle.
The chip is pressed downwards and leveled horizontal with the fiber array
when the cover part with fluidic connectors and integrated flow-cell is pushed
down. An integrated Viton O-ring assures a leak thigh connection between the
photonic chip and the cover part and, at the same time, creates the microfluidic
flow-cell over the sensor surface.
A clamp mechanism presses the photonic chip into a predefined corner
of a frame. This assures a first rough alignment of the chip with the fiber
array with micrometric resolution. The frame where the fiber array and the
sensor chip are placed is milled in a single movement, ensuring a minimal
alignment inaccuracy on the non adaptable pitch, roll and yaw axis. Hor-
izontal leveling of chip to fiber array is accomplished when the cover part
with integrated connectors for fluidic capillaries is pushed down onto the
chip. In the same movement, a 200 µm height flow-cell is created by an in-
tegrated Viton O-ring underneath the cover part which seals off an elliptical
area between the two connectors and the sensor area. Fine tuning of the
alignment is then realized by maximizing the output signals with y and z
movements.
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3.3 Microfluidic flow-cell
One of the fundamental components of any biosensing system is a microflu-
idic flow-cell. This has to be designed in a way that
• it includes all sensing area of the biosensor in order to homogeneously
wet the sensor’s surface,
• it has a volume that permits a continuous laminar flow of flowing so-
lutions,
• it is preferable to have a flow-cell made by a transparent material that
makes possible to follow the flow evolution near to the sensor surface.
A part from these important properties of flow-cells, one has to consider
ways for avoiding air bubbles while flowing liquids. When there are air
bubbles, they simply can cover a sensing surface and not allow the target
solutions to interact with sensor. Air bubbles can form from microfluidic
material itself if it will chemically react with flowing solutions. Another
reason of bubble formation can be a very tighten alignment of microfluidic
on the sensor surface.
Considering these requirements, several microfluidic flow-cells have been
proposed. Here I will present the two that I worked with.
3.3.1 Flowcell integrated to the alignment stage
On the alignment stage discussed above, a flow-cell is created by an inte-
grated Viton O-ring (see Figure 3.10b) underneath the cover part which seals
off an elliptical area between the two connectors and the sensor area. Flow
cell is made from PMMA that is well known for these type of applications
for its low molecule adsorption. Note, that all tubings and connectors in a
loop are from PMMA as well. Microfluidic flow-cell can be pressed down
against the chip using a screw as it is shown in Figure 3.10a. At that mo-
ment the O-ring seals off the sensor area and the enclosed area inside acts
as a microfluidic flow-cell. On the Figure 3.10b in red the connectors for the
fluid tubes (for tubing with 1/32” OD). The surface of that area is ≈22×106
µm2.
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(a) (b)
(c)
FIGURE 3.10: (a) The schematic of the flow-cell positioning against the chip. (b)
The picture of the microfluidic cell. It contains two fluidic ports and an O-ring
that forms a flow-cell. In red the connectors for the fluid tubes with 1/32” OD.
(c) Further modifications of the microfluidic flow-cell.
During squeezing the microfluidic its actual height changes which can
cause liquid flow blocking and the air bubble formation. In order to op-
timize the flow-cell height, I tested three flow-cells with different heights
(100µm, 150µm and 200µm) and followed the formation of air bubbles. Ta-
ble 3.1 reports the results3 of these tests.
3In a scale of 1 to 10, 10 means an easy removing of an air bubble with fast flow rate, while
1 means that it is needed to untight the screw that fixes the microfluidic and use a high flow.
This leads to a misalignment of the sensor and to a probable leakage.
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TABLE 3.1: Characteristics of microfluidic flow-cell depending on the cell
height.
Height Number of bubbles per hour Easy to remove bubbles
µm In scale of 1 to 10
100 >30 1
150 >10 5
200 >2 9
Finally, according to these results, for the final measurements of anti-
biotin sensing the flow-cell with 200 µm height was chosen.
A possible modifications of the microfluidic is shown in Figure 3.10c. By
placing the input and the output capillaries on the side of the microfluidic
and by using a transparent PMMA one can achieve a desirable visibility of
the chip and, respectively, of the sensor (MRR or aMZI) under the flow-cell
which makes possible to get an immediate information about bubble arrival
and flow behavior.
3.3.2 Flowcell from PDMS
The alternative to the microfluidic flow-cell discussed above, can be a flow-
cell from PDMS that is made in UNITN. PDMS was chosen in order to obtain
a leak-tight sealing between microfluidic and chip. This elastomer has been
vastly adopted in the field of microfluidics, because it can be easily cast,
even in molds with submicrometric features. When solid, its elastic proper-
ties make it a good sealant. The geometry of a flow-cell is limited by the chip
dimensions. Our MRR based chips typically have 5 mm×3 mm surface and
the area where MRR sensors are located is typically 500 µm large, while for
aMZI sensors the sensing window is 660 µm and thus demanding a flow-
cell at least 700 µm. A flow-cell that fulfilled the requirements was fabricate
by using a milled PCB as a mold for the PDMS casting. In Figure 3.11a it
is shown the geometry of the flow-cell that was used in all experiments on
MRR and in some on aMZI sensors. The inner 800 µm×100µm×5 mm vol-
ume corresponds to the flow-cell that covers all the sensing area on the chip
(see Figure 3.11b).
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FIGURE 3.11: (a) Schematics of fabricated PDMS microfluidic. The inner part
of 800 µm×100µm×5 mm volume corresponds to the flow-cell that covers all
sensing area on the chip. (b) Microscope top-view picture showing the align-
ment of the flow-cell to the sensing arms of three aMZIs on the chip. (c) Side
view of a PDMS flow-cell. The system consisting from the PDMS and 150 µm
of ID capillaries are fixed on the plexiglass piece with epoxy glue.
The PDMS is prepared by mixing the elastomer, Dow Corning Sylgard
184, with the curing catalyst in 10:1 ratio. While the mix is still liquid, it is
poured on the mold and placed in a vacuum chamber for 30 minutes. After
degassing, still liquid PDMS is cured in room-temperature within maximum
48 hours. After carefully removing solid PDMS from the mold we cut and
separate the pieces that correspond to microfluidics. Next by drilling we
make halls of 600 µm diameter on the top and bottom of flowing area for
satisfying liquid in and out condition. And finally we insert capillaries of
150 µm inner diameter (ID), into the holes for creating free liquid flow from
the pump to the chip and out. In order to achieve a stable and easy alignable
microfluidic system, a PDMS flow-cell and capillaries are fixed together in
a middle of 1 cm long and 3 mm large plexiglass piece with bi-component
epoxy glue (see Figure 3.11c). It completely becomes solid in almost four
hours.
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This way of fabrication of microfluidic flow-cells has few significant ad-
vantages, such the possibility to fabricate and glue up to fifteen flow-cells at
the same time where each all is 2 mm wide and from 4 to 6 mm long.
3.4 Liquid flow module
In this section we will discuss two kinds of liquid flow modules to realize
the necessary flow (i.e., continuous or oscillating flow) at the desired flow
rates.
3.4.1 Syring-pump continuous flow
In biosensing measurements, there is always the need of switching between
different solutions, i.e., buffers and target solution. Therefore, in our setup
we used a pump that provides continuous flow and a 6-way loop injection
valve for multi-solution injections. We choose a VICI M6 syringe-free pump
and a VICI C1CF valve, which are shown in Figure 3.1 and are zoomed
in Figure 3.12. The pump is able to feed an unlimited volume of carrier
solution, usually the incubation buffer, to the sensor without interruptions.
The patented M Series liquid handling pump is a syringe-free pump ca-
pable of delivering a bidirectional flow over six orders of magnitude. The M
Series is a positive displacement pump, which means that it is self-priming
and tolerant of any gas which may find its way into the fluid lines which
prevents bubbles formation. There is no separate fill cycle, and the capacity
is unlimited.
This pump supplies a flow range of 5 nl/min to 5 ml/min (10 ml/min
intermittent). USB and RS-485 communication protocols are incorporated
into the micro- processor-driven controller. The included software package
controls flow rates, flow direction, and metered volumes.
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FIGURE 3.12: (a) Picture of the VICI M6 continuous flow pump, connecting
a buffer reservoir to the injection valve. (b) Picture of the VICI C1CF injection
valve at the moment of injection of target solution. The numbering corresponds
to: (1) VICI M6 continuous flow pump, (2) 6-way loop injection valve, (3) sam-
ple loop, (4) waste collecting reservoir, (5) Hamilton syringe, 700 series, fixed
blunt needle.
Continuously flowing as well as injected solutions final flow directions
to the sensor are controlled by an injection valve. By switching a valve,
small volumes of injected sample solutions can be delivered to the sensor in
the flow of small liquid plugs, implanted in the continuous stream of carrier
baseline solution. The working principle of such valve is demonstrated in
Figure 3.13. When the handle is set to “load”, the inner rotator connects
the sample injection port to the sample loop (i.e., a piece of PMMA tube of
known volume) by 1-6-3-2 way, and the pump port (i.e., a carrier or baseline
liquid entrance port) to the sensor port by 4-5 way, hence making possible to
fill the sample loop with the target solution, without interrupting the flow
towards the sensor. When the handle of the valve is set to “inject” position,
the inner rotator switch the connections, directing the sample injection port
directly to the waste by 1-2 way, while the flow of carrier liquid pushes the
sample in the capillaries towards the sensor by passing 4-3-6-5 loop.
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FIGURE 3.13: Schematic representation of the working principle of an injection
valve. (a) When the valve is in “load” position, the sample loop can be filled
with the analyte solution through the injection port, while the flow of carrier
solution remains uninterrupted. (b) When the valve is in “inject” configuration,
the carrier solution without mixing pushes the fixed-volume plug of analyte
solution towards the sensor.
One of the many advantages of this valve is the “bubble-free” insertion
of the sample solution into the loop between a pump and a sensor. The
volume of the analyte solution is defined by the volume of sample loop,
that can be minimized. The smallest volume that we used was 20 µL, but it
can be still reduced.
For the final integration of SYMPHONY system, this loop played a highly
important role, i.e., a connection between sensor and concentrator modules.
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3.4.2 Oscillating flow pump
The second liquid handling unit which was built in Lionix enables execu-
tion of automated sample injection and washing. The main part of the liq-
uid handling system consists of two (micro) peristaltic pumps, three valves,
and the associated vials and tubing (P625/275 pumps and pump tube set
P625/ TS020P (Instech Laboratories, Inc., USA)). In Figure 3.14a the experi-
mental system used for anti-biotin experiments is shown. The liquid han-
dling module is the lower instrument on the picture.
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FIGURE 3.14: (a) A picture of an experimental apparatus for anti-biotin studies.
Numbers correspond to: (1) Liquid handling module, (2) signal readout system
system (OSROM), (3) alignment stage, (4) some sample reservoirs, (5) waste
container, (6) computer connected to the pump and OSROM for system control
and data registration. (b) The calibration of the volume of liquid in the output
of the pump. Blue dots refer to expected liquid volume, while the black ones are
the real measured ones. Red curves shows data fitting from where we extracted
the accuracy of the flow rate.
Pumps and valves are operated via LabVIEW software. The pump can
deliver 0.4-7 µL/s flow rate. The flow rate is conditioned by the given volt-
age that drives the pump. The relationship is given by:
F = 1.40078×V , (3.1)
where F is a flow rate, V is a voltage and 1.40078 µL/(sV) is a constant
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for the pump system. We used this relationship for the pump calibration.
Through the software we set the flow rate, that was converted to the voltage
and drove the pump. We aimed to flow 1 mL of solution (MilliQ in this
case). The continuous flow duration was 1 mL/F. The flow duration was
inserted to the program and when it finished the pump stopped working.
We collected the liquid in the output of the pump in a reservoir and measure
the real volume. Figure 3.14b shows that for small flow rates we measured
different volumes (black dots) from what expected (blue dots). From data
fit we got the relationship between the flow rate and the flowing volume.
This system allows an automatic switch between up to 8 solutions, such
as buffer, water, cleaning solution, regeneration solution and sample, with-
out changing reservoirs or moving tubings.
In parallel there is an alternative supply route for sending an analyte
to the sensor via a so-called load/inject valve.This load/inject valve is sup-
plied with a sample loop consisting of tubing of a certain capillary volume.
The filling of the sample loop is conducted by an independent pump and
can therefore be executed apart from the main supply toward the chip. The
advantage of the use of an extra pump and valve is that loading of the sam-
ple loop can be done simultaneously. Measurement of the baseline then is
done during infusion of buffer over the chip surface while the sample loop
is being filled with sample. After filling the sample loop, its content can be
injected over the chip by switching from load mode to inject mode. Cleaning
and flushing of the sample loop and associated tubing serve to prevent con-
tamination and carry-over between consecutive loading and measurement
runs.
One way for incubation with sample, apart from unidirectional flow, is
by using the oscillating flow. The oscillating flow in some sense shakes the
analytes within the microfluidic volume, thus insuring a homogeneous cov-
erage of the ligands, immobilized on the sensor surface, by the analytes. In
the case of oscillating flow, the center of a sample plug is brought toward
the middle of the sensor by a timed pumping. Flow is stopped then after
which the sample plug is repeatedly moved back and forth over the sensor
by pumping alternately in one and the other direction, at a volumetric flow
rate down to 0.4 µL/s. The clear advantage of the oscillating flow approach
is that, even with prolonged incubation, only a limited sample volume is
needed.
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3.5 Signal read-out systems
Finally, one of the most critical parts of any biosensing system is the signal
read-out block. The correctness of the biosensing measurement depends
on how sensitive is the readout system and how much is the contribution
of noises for the signal reading. Here we will discuss two approaches for
signal real-time detection and monitoring.
3.5.1 OSROM
One of many techniques for signal processing is the Fourier Transform al-
gorithm. This is at the bases of the so-called OSROM read-out system, built
in LioniX (see Figure 3.14a), hence many details are not presented here.
OSROM contains a pigtailed VCSEL (type ULM850, TO46, 2.0 mW; ob-
tained from Philips Technology GmbH, U-L-M Photonics, Ulm, Germany) and 8
PIN photodiode detectors (PD) for simultaneus detection of the signal from
different sensors, plus associated electronics and a built-in DAQ unit. Other
parts of the OSROM are a current source for driving the VCSEL diode as
well as a thermal controller of the embedded VCSEL. OSROM is suitable for
the fiber array placed on the alignment stage described in the section 3.2.3.
The experimental data reported in section 4.1.4 have been acquired by the
OSROM system.
3.5.2 SYMPHONY signal acquisition
In this thesis I will mainly concentrate in data analyzes extracted from sig-
nal acquisition method realized in UNITN. In all discussed setups the out-
put light is sent to a commercial Si transimpedance amplified photodetector
from Thorlabs (PDA36A) interfaced to a PicoScope 4824 (an 8 channel USB
oscilloscope) from Pico Technology. The PicoScope 4824 mix of 8 channels,
high resolution and deep memory makes it suitable for a wide range of ap-
plications that cannot be met by traditional benchtop oscilloscopes. 12 bit
resolution both for the oscilloscope and spectrum analyzer helps track down
noise, analyze harmonics and measure distortion. Even though Picoscope
4824 has his own software for signal analyzes, therefore we connected it to a
computer through the LabVIEW interface developed by us particularly for
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the SYMPHONY system, i.e., VCSEL signal detection and biosensing mea-
surements. Basically, we read the synchronization signal of the sawtooth
function generator (modulation frequency of 20 Hz), which drives the cur-
rent of the VCSEL and provides the wavelength scanning. Then we infer
the direct modulation voltage from the moment passed from the trigger.
Voltage-wavelength transmission is done by inserting in the LabVIEW code
the results of the third order polynomial fit, shown in Figure 3.5b.
First, we acquire the output signal from VCSEL and save it as a nor-
malization reference. By this way, we do not occupy a channel from the
Picoscope for a reference signal. Then, the transmission spectra of simulta-
neously measured MRR or aMZI sensors is recovered by normalizing with
the saved VCSEL reference signal. For every acquired spectrum, a Matlab
script, embedded in the LabView code of the acquisition program, analyzes
the data and extract the signal used for the sensing. The algorithms are dif-
ferent, depending on the kind of photonic sensor.
In the case of MRR, we choose a wavelength scanning range which in-
cludes one resonance. Within this range, the resonance wavelength is roughly
estimated by finding the minimum value in the transmission. Then, by ap-
plying a Lorentzian fit, we extract the Q-factor and resonance peak posi-
tion. Next, we perform a real-time monitoring of the resonance peak po-
sition. Thus the biosensing measurements becomes a measurement of the
resonance wavelength variation in time. By using the Matlab script, it is
possible to follow this variation in real time.
In the case of the aMZI, the algorithm is slightly different. Here a sinu-
soidal fitting on the data is performed. Knowing the frequency of the sinu-
soidal to be fitted, which is indeed the FSR, one can extract the amplitude
and the phase from the Matlab script. In this case we monitor the time de-
pendence of the phase value, which is later transformed to the wavelength.
This algorithm allows to measure the wavelength shift for both MRR
and aMZI sensors down to 10 fm. The velocity of the measurement is deter-
mined by the PicoScope, which supports up to 80 MS/s sample rate.
3.6 SYMPHONY integrated system
The last section of this chapter is dedicated to description of the complete
system development within the collaboration of the SYMPHONY European
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project, i.e., the integration of the full system that is able to perform a com-
plete analyses of milk samples against AFM1 presence. The system consists
of three main subsystems. Due to the complexity of milk which is a matrix
combining different molecules with different properties and sizes, it is a big
challenge to build a module that can treat milk. AFM1 is a small molecule
(327 Da) and in order to have a selective optical biosensor for AFM1 detec-
tion at low concentrations such as 50ng/ml, we first treat milk samples pass-
ing them through a fat removal module where we purify milk from proteins
(mainly casein), vitamins, sugars and other disturbing components. Then,
the purified samples are sent to a concentrator module, that is capable to
concentrate the purified milk samples up to 20 times. The resulting liquid
(eluate) then is injected on the sensor to sense the presence of toxin. The
schematics of the system is shown in Figure 3.15.
Fat removal module
Concentrator module
Detection module
FIGURE 3.15: The principal modules of the SYMPHONY device: contaminated
milk sample passes through the fat removal unit where fat, protein molecules
are removed, then it undergoes a concentration process, after which it is sent to
the photonic sensor.
The fat removal or defatting module was designed and built by FBK
MST (MicroSystems Technology) group. It was implemented with commer-
cial tangential flow filter (TFF) modules and it was composed of:
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• a peristaltic pump (flow rate 30ml/min, overpressure 1 bar; recom-
mended for best flexibility: flow rate up to 60 ml/min, 2 bar overpres-
sure);
• a custom-made TFF assembly, using a custom milled membrane holder
and a 20 µm pore nylon net by Millipore;
• a Pellicon TFF cassette pore 0.65 µm, accepting about 30ml/min from
previous stage;
• a manometer for pressure check;
• recirculation of the retentate and collection of the processed sample in
a vial.
For the further purification of milk samples the defatting module was
accomplished with a chemical treatment that made possible to separate the
most part of proteins. Milk sample preparation steps are described in Ap-
pendixB. Prepared sample then passed through the concentrator module,
where the fundamental role was played by bullet designed by the partners
ACREO and EPIGEM. The "bullet" consisted of a multiple stack of Nickel
metal meshes (390 meshes in total) comprising an array of high surface area
metal wires and an array of holes.
The working principle of bullet is following: it collects the relatively
small number of AFM1 molecules in a relatively large sample volume and
then subsequently eluates the collected molecules into a small known vol-
ume of clean material (i.e. concentration). In order to capture the AFM1
molecules, meshes were functionalized with anti AFM1 antibodies. The
high surface area metal wires were stacked and achieved the specified high
surface area within a 100µL volume. The concentrator was meant to concen-
trate AFM1 in buffer solution from 20 to 50 times. The bullet was designed
to contain about 180 µL of fluid. Typical elution volume was smaller, ≈ 130
± 20 µL. Out of this volume ≈ 40 µL of eluate is injected into a detector
module.
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FIGURE 3.16: (a) The modules of SYMPHONY device connected with tubings.
(b) TFF 20 µm filter assembly. (c) Concentrator unit and the schematics of the
bullet.
Figure 3.16a represents the real system that was demonstrated in the fi-
nal review meeting of the project. Despite the fact that the overall picture
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of the system is not the one that was planned from the beginning, but the
transfer of milk sample from one module to another is realized by just a sin-
gle tube, thus securing the concern of an integrated system for milk analyses
against AFM1. The integration between the first two units was easily real-
ized by connecting deffater output and concentrator input tubes to the same
reservoir where a protein and fat free milk sample was collected. Yet the
most challenging part was the connection between the concentrator and the
detection modules. In the output of the concentrator module, we got eluate
relieved under high pressure and thus full of air bubbles. The presence of
an air bubble on the sensor surface is determined a "fake" resonance/phase
shift as a result of liquid-air refractive index changes. Taking account this
issue we decided to have a reservoir after the concentrator, where we could
collect the eluate and clearly see when air bubbles separated from liquid
part. Hopefully we were able to have the required volume of eluate free
of bubbles after few seconds already. Finally, the injection of eluate to the
photonic sensor took place by using a syringe pump described in section
3.4.1 and a Milliliter Syringe Pump Module from Harvard Apparatus in with-
draw mode in order to fill the sample loop of the valve as it is shown in
Figure 3.17a.
The movements of the second pump are controlled through the same
software as the concentrator and detector (see Figure 3.19).
When the valve is in “Load eluate” position, the sample loop can be
filled with the eluate through the load port by dispensing the Harvard Appa-
ratus syringe pump, while the continuous flow of carrier solution remains
uninterrupted thanks to the first VICI pump. Here we deal with 2-3-6-1
and parallel 4-5 flow directions (see Figure 3.17a). We carefully filled in the
volume of 30 µL of loop avoiding an injection air bubbles as well, and im-
mediately switched the valve in position "Inject eluate", where the carrier
buffer pushed the eluate to the sensor by 4-3-6-5 routine (see Figure 3.17b).
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FIGURE 3.17: Schematic representation of the working principle of an injection
valve in integrated system.
In Figure 3.18 we show the final integrated system of concentrator -
detector modules. Detector, i.e., aMZI chip was placed on the alignment
stage. The signal read-out is carried out by the same LabVIEW program
that is already discussed in the section 3.5.2.
The sensor board was designed in collaboration with FBK. We devel-
oped a final software interface for the whole SYMPHONY system, that in-
cluded concentrator, Harvard Apparatus syringe-pump and sensor board con-
trols. Figure 3.19 shows the SYMPHONY interface. The white curve shows
the sensorgram that was measured in this system.
3.6. SYMPHONY integrated system 81
2
1
5
6
3
4 7
VCSEL
PD
FIGURE 3.18: Concentrator-detector integration. Numberings correspond to:
(1) bullet, (2) eluate reservoir, (3) Harvard Apparatus syringe pump, (4) align-
ment stage with aMZI chip on it, (5) VICI pump, (6) sensor board, (7) computer
that is connected with the board through USB and which runs a software.
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FIGURE 3.19: The interface of SYMPHONY integrated system. Numberings
correspond to: (1) concentrator control, (2) Harvard Apparatus syringe pump
control, (3) sensor board read-out interface.
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Results and discussions
In this chapter the results of the biosensing experiments performed with
the sensors that have been developed during my PhD are presented and
discussed.
In § 4.1, results on the SiON microring resonator based photonic sensors
will be presented in terms of bulk sensitivity, limit of detection, AFM1 de-
tection in buffer solution. Based on the validation of the functionalization
method, a sensor is developed with an asymmetric Mach-Zehnder interfer-
ometer. Section 4.2 reports the characterization of the aMZI photonic chip.
Finally, AFM1 detection first in buffer, then in the milk samples is demon-
strated. The lowest detectable concentration of AFM1 with SYMPHONY
system is defined.
The last § 4.3 is focused on the development of affinity biosensors as an
application of TripleX based photonic chips, in particular multi-MRR config-
uration for biotinylated BSA-anti-biotin molecular interaction study. Eight
cycles of sensor regeneration processes are successfully realized.
4.1 Microring Resonators for AFM1 detection
I started my PhD research after the first year of SYMPHONY project, when
the final design of the photonic biosensor was completed. A multi-MRR
chip shown in Figure 4.1 was fabricated. These devices were from the BS2
and BS3 wafers.
For the measurements of these chips, the waveguide-probing setup pre-
sented in Figure 3.1 is used with the only difference that a fiber array is cou-
pled to the chip outputs. The fiber array allows measuring simultaneously
the transmission of four different microrings.
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FIGURE 4.1: An image of MRR based chip. On the left, the bright spot is the
laser scattering at the input waveguide. On the right, the fiber array is visible.
On the chip, the location of the four microring resonators is indicated.
4.1.1 Optical characteristics of MRR chips
The chips from the BS2 and BS3 wafers are characterized. Table 4.1 reports
the optical characteristics of covered MRR (SiO2 cladding is present) for BS2
and BS3 wafers. To guarantee single mode operation and to limit propaga-
tion losses, was decided to keep the width of the bus waveguide at 900 nm
and of the ring one at 1000 nm, respectively. In the work [126] are shown
the results of the simulations and optical characteristics of the following ge-
ometries.
Propagation losses as low as 0.8 dB/cm for 350 nm×950 nm waveguides
were measured in TE polarization. For the same waveguide geometry bend-
ing losses in the curve with radius of 100 µm were found to be 0.1 dB/90◦.
Directional couplers based on such waveguides demonstrated 49/51 split-
ting ratio for 65 µm-long coupling zone.
The results of the experimental observations yield the fact that the pho-
tonic chips from both BS2 and BS3 wafers show the similar performances
regarding to the losses. However, the Q-factor for the MRRs from the BS3
wafer is slightly higher in comparison with the one of BS2 wafer, as a reason
of the wider waveguide and, consequently, the better confinement of the
guiding mode in the bus waveguide (wBS3=350 nm>305 nm=wBS2).
Next, we characterized MRRs with opened sensing windows for both
wafers. As it is already described in § 3.1.1, 20 µm wide sensing windows
are opened on three of the four MRRs. The removing of the SiO2 layer yields
a change in the refractive index of the cladding, resulting in a lower mode
confinement and, consequently, in a Q-factor change. After the opening of
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the sensing windows, we noticed that for TM polarization of BS2 chips the
resonance peak vanished. This can be explained with the etching uncertain-
ties, that can either have introduced more surface roughness, increasing the
surface losses, or have altered the geometry of the waveguides, increasing
the radiative losses such that only TE polarization is guided. We performed
the sensing measurements only for TE polarization in case of BS2 chips, and
both TE and TM polarizations in case of BS3 chips.
In Figure 4.2a we report an example of a transmission spectra, taken for
BS2 sample when the resonator is covered with water. The measured Q-
factor in this figure is the maximum for BS2 wafer. Note, the transmission
is normalized by VCSEL reference signal. In order to obtain the loaded Q-
factor, we performed Lorentzian fit of the resonance peak. The maximum
Q-factor of 4×104±40 was extracted, correspondingly to an extinction ratio
of ER=5dB, calculated according to Eq. 2.18. More than ten chips from this
wafer have been measured and for the mean value of 3.1×104 with standard
deviation of 9×103 was calculated for the loaded Q-factor (see Figure 4.2c).
Such variation of the Q-factor can be explained with fabrication uncertain-
ties as well as by the inhomogeneous absorption losses of the water while
changing from chip to chip. However the peak resolution is sufficient for
further sensing measurements.
A significant difference was observed for the chips from BS3 wafer re-
ported in Figure 4.2b. For BS3 chips the resonance peak for both TE and
TM polarizations is observed. The maximum Q-factor of 1.3×105±500, cor-
respondingly to extinction ratio of ER=7 dB for TE polarization and the Q-
factor of 5×104±90, with ER=4 dB in case of TM polarization are measured
for the same MRR. Repeated measurements for a number of chips for the
loaded Q-factor show a mean value of 5.5×104 with standard deviation of
104 in case of TM and mean value of 11.5×104 with standard deviation of
1.5×104 in case of TE polarization, respectively (see Figure 4.2c). For the
TE polarization the loaded (measured) quality factors are about twice of the
ones observed for TM polarization, and this trend was obtained for all chips.
It is caused by the fact that TE mode is more confined in the waveguide than
the TM mode.
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FIGURE 4.2: Normalized transmission spectra for (a) TE polarization of the mi-
croring resonator from BS2 wafer, and (b) TE and TM polarizations of the mi-
croring resonator from BS3 wafer. Q-factors are extracted from the Lorentzian
fit. (c) The mean values of the Q-factors, calculated for more than 10 chips from
each wafer.
4.1.2 Sensitivity and Limit of Detection
After optical characterization, bulk sensitivity (Sb) measurements are per-
formed and, consequently, the LOD of the system is determined.
In order to calculate Sb, we monitored in real-time the spectral shifts of
the whispering gallery mode (WGM) resonances of the microrings, while
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the sensors were exposed to glucose-water solutions of various concentra-
tions. The refractive index of such solutions can be easily measured or es-
timated. Empirically it has been demonstrated a linear dependence of the
refractive index from the glucose-water solution concentration up to 20%
(1% = 1 gm/100 ml) solution [127]. According to this relationship, the re-
fractive index variation can be calculated as:
∆n = 0.0015× C , (4.1)
where C is glucose concentration in gm/100 ml units.
Volumetric sensing measurement is started with flowing a buffer solu-
tion, in this case MES buffer, simultaneously on three microring resonators
on a single chip from BS2 wafer. The choice of buffer is due to the use of
the same buffer for the measurements, so that we keep the same environ-
mental conditions. Continuous flow at 20 µL/min flow rate is used with the
VICI pump described in § 3.4.1. For this measurement a sample loop with
≈75 µL is used, thus yielding ≈3.7 minutes flow of injected solution over
the sensor. Figure 4.3a represents the temporal evolutions of the resonance
wavelength (sensorgram) upon subsequent injections of solutions at differ-
ent concentrations. The first injection is pure water that plays the role of the
baseline for glucose-water solutions. When water is injected a negative shift
of the resonance wavelength is observed, since the refractive index of water
is smaller than the one of MES. As it is expected, all three microrings demon-
strate similar performances, showing the similar shift. After ≈3.7 minutes,
when MES again arrives to the sensor the resonance wavelength recovers
the initial value corresponding to 0 nm. Next injection is 0.1% glucose-water
solution that yields a resonance shift smaller than previous, due to the rel-
atively higher refractive index in comparison with pure water. Injections
are repeated for 0.2, 0.3, 0.4 and 0.5% of glucose-water solutions. With the
increase of glucose concentration one can clearly distinguish an increase of
the difference between pure water and glucose-water solutions.
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FIGURE 4.3: Bulk sensitivity measurements on BS2 sample. The variation in
refractive index is obtained by injections of water-glucose solutions at different
concentrations. (a) The temporal evolutions of the resonance wavelength upon
subsequent injections of solutions at different concentrations, (b) correspond-
ing resonance wavelength shifts linear fit for TE polarization, (c) shift taken in
24 seconds of MES flow. (d) The mean values of bulk sensitivity, calculated for
more than 7 chips for TE polarization of BS2 and both TE and TM polarizations
for BS3 chips.
Figure 4.3b represents resonance shift, taken as a difference of the maxi-
mum absolute values of the shift for each concentration and the shift due to
pure water, as a function of the bulk refractive index variations calculated
according to Eq. (4.1). The slope of the linear fit corresponds to Sb, which is
≈70 nm/RIU for the three MRR sensors. The difference of the sensitivity for
these MRR is <1%.
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In order to obtain the limit of detection (LOD) of the system, the stan-
dard deviation of the signal is taken in a region where only the buffer is
flowing. We took a period between 0.4-0.8 minutes of the sensorgram (see
Figure 4.3c). The standard deviations for all three MRRs are similar, thus we
can take the average value of σ = (8.3±0.2)×10−5 nm. LOD for this particu-
lar chip calculated by Eq. (2.4) is equal to (3.5±0.1)×10−6 RIU.
The same protocol was used for all the three cases, i.e., BS2 chips in TE
polarization and BS3 chips in both TE and TM polarizations. Figure 4.3d
shows statistically obtained values of the bulk sensitivity for these cases.
The best sensitivity for BS2 wafer in TE polarization (note, we do not ob-
serve a resonance in TM polarization) showing Sb = (80±12) nm/RIU aver-
age value, is calculated for more than 7 chips. Very close values are mea-
sured by the BS3 chips for TM polarization, i.e., Sb = (70±8) nm/RIU, and
finally the lowest sensitivity is observed for the BS3 chips in TE polariza-
tion of Sb = (55±6) nm/RIU. Although, all the experimental conditions were
kept constant, still there are several reasons for the variation of the sensitiv-
ity, such as temperature in laboratory, glucose concentration small variation
for each preparation, chip differences coming from the fabrication and so
on. However these differences in the sensitivity do not have a significant in-
fluence on the limit of detection. Measured LOD for all cases is in the range
of (3÷6)×10−6 RIU.
Comparing our devices in terms of both bulk sensitivity and LOD with
the state of art, we can see that BS2 and BS3 chips have similar characteristics
with the other structures shown in Table 1.2. In particular, the LOD for
different types of devices, varies in the range of 10−6 - 10−7 RIU.
4.1.3 MRR surface functionalization
After a sensor chip is characterized in terms of the Q-factor, bulk sensitivity
and LOD, its surface is treated chemically, i.e., it undergoes a functional-
ization process in order to selectively detect a target molecule, in particular
AFM1 in this case.
Two different protocols were developed based on DNA-aptamer and
Fab’ in order to identify the best one in terms of high reproducibility, sta-
bility and selectivity of the surface functionalization. It was demonstrated,
that even though there are several properties of the aptamers, such as the
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stability to long-term storage or the more economic prices, the antibodies
were more reproducible and sensitivity to AFM1 detection.
Development of the functionalization procedure was performed by Laura
Pasquardini. In § 4.1.3.1 and § 4.1.3.2 the functionalization protocols based
on DNA-aptamers and Fab’ are described, respectively.
4.1.3.1 Aptamer based functionalization strategy
The functionalization procedure performed on the sensors is based on wet
silanization protocol. After a cleaning process (with a Piranha solution)
to remove organic contaminations the samples were immersed in 0.01%
v/v of GPTMS (3-glycidoxypro-pyl methyldiethoxy silane) in anhydrous
toluene at 60 ◦C for 10 min. Then an amino-terminated DNA-aptamer (5’-
NH2-(CH2)6-GT TGG GCA CGT GTT GTC TCT CTG TGT CTC GTG CCC
TTC GCT AGG CCC ACA-3’) at 100 µM in phosphate buffer (50 mM, ionic
strength 300 mM, pH 8) was incubated on silanized surfaces for 2 h. The ap-
tameric sequence with a kD of 10 nM was identified by NeoVentures Biotech-
nology Inc. [128]. The amino-modified sequence is HPLC purified and was
purchased from IDT Integrated DNA Technologies (Leuven, Belgium). Fi-
nally, an ethanolamine passivation at 1 mM for 30 min was applied.
4.1.3.2 Fab’ based functionalization strategy
F(ab’)2 fragments are generated by protease digestion (Immobilized Papain
Thermo Scientific) of 20 µL of 1 mg/mL anti-AFM1 polyclonal rabbit IgG
according to manufacturer’s instructions. Then, a 13.3 µM F(ab’)2 solution
is mixed with 10 mM DTT to reduce the disulphide bond in the hinge re-
gion, and the mixture is incubated for two hours at room temperature. The
mixture is poured into a centrifugal filter unit (Microcon YM-10, MWCO
10000, Millipore Corp., Billerica, MA, USA) to remove the excess of DTT.
Fab’ are immobilized on the surface adapting the protocol described in [129].
In order to introduce thiol groups able to react with the cysteine groups on
Fab fragments, the silicon oxynitride surface is functionalized in wet con-
ditions with mercaptosilane (MPTMS) [130]. The surfaces (both chip and
flat samples) are cleaned with an argon plasma (6.8W, one minute) to re-
move organic contaminants and to hydroxylate the surface and are, then,
immersed in a 1% v/v solution of MPTMS in toluene anhydrous at 60 ◦C for
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10 min. Silane-coated substrates are rinsed several times with toluene and
then dried in a stream of nitrogen. The immobilization of Fab’ fragments
onto the bare surface is carried out by deposition of 80 µL of a 0.33 µM Fab’
in 10 mM phosphate buffer with 10 mM EDTA. After 2 min, the surface
is PEGylated by addition, first, of 200 µM final concentration of mPEG-SH
5000 (for 30 min on orbital shaker at 80 rpm) and, then, of 200 µM of mPEG-
SH 2000 (for 60 min on shaker at 80 rpm). The surface is finally cleaned
using PBS-EDTA buffer. The same protocol is applied on standard flat gold
surface. The concentration of Fab’ is determined by measuring their ab-
sorbance with a Nanodrop instrument, (extinction coefficient (0.1%) =1.35
at 280 nm).
4.1.3.3 Comparison of the surface functionalization strategies
The Fab’ density on silanized SiON is optimized incubating different con-
centration. After immobilization, the surfaces is incubated with an HRP-
conjugated AFM1 (AFM1-HRP) stock solution diluted 80 times in 50 mM
MES buffer pH 6.6 for one hour, washed twice in buffer and transferred to
a black microplate, where the developer solution is added. HRP in pres-
ence of a suitable substrate develops a chemiluminescence signal that can
be easily detected. After five min incubation, the signal is recorded with a
ChemiDoc MP system (Biorad). Respect to a gold surface (a standard sur-
face for thiol chemistry), a saturation of the surface is obtained at low Fab’
concentration, as reported in Figure 4.4a. Fitting the data with a Langmuir
equation, it is possible to determine the surface saturation. For SiON surface
the value saturates at 2957 a.u. (correlation coefficient = 0.99), while for gold
surface a 18588 a.u. value was estimated (correlation coefficient = 0.97). The
signal recorded on silanized SiON surface is about 6 times lower than that
recorded on gold, suggesting that the surface binding sites on mercaptosi-
lanized SiON are fewer than those on gold surface, as expected. A 0.33 µM
Fab’ concentration is selected for the following experiments.
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FIGURE 4.4: (a) Chemiluminescence detection of AFM1-HRP on SiON sub-
strates after immobilization of different amount of Fab’. A gold substrate is
used as reference. The values are reported as mean value on at least two differ-
ent experimental sessions and the error bars represent the standard deviation.
(b) Fluorescence signal on SiON surface functionalized with different amount
of fluorescent aptameric sequences. The values are reported as mean value on
three different samples and the error bars represent the standard deviation. (c)
Chemiluminescence detection of AFM1-HRP on SiON flat surfaces functional-
ized with Fab’ or aptamer strategy. The data are represented as mean value on
three samples and error bars are reported as standard deviation.
The aptamer density is instead optimized using a fluorescent- labelled
DNA aptameric sequence. The fluorescence signal is recorded after two
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hours of incubation and washing. Figure 4.4b shows the fluorescence sig-
nal as a function of the aptamer concentration. Also in this case the Lang-
muir equation describes the aptamer immobilization. The saturation level
resulted at 5970 a.u. (correlation coefficient = 0.98), suggesting that a con-
centration above 50µM is enough to reach the surface saturation. Then, the
two functionalization procedures are compared with respect to their abil-
ity to recognize AFM1 by using AFM1-HRP. SiON flat substrates are func-
tionalized with DNA-aptamers or Fab’ and the surfaces are incubated with
AFM1-HRP in the same conditions reported above. The signals recorded
on the Fab’- or aptamer- functionalized surfaces are reported in Figure 4.4c.
A higher signal is observed for the Fab’-functionalized surface. The AFM1
detection is about 5 times more efficient on the immune surface respect to
the aptamer-functionalized surface.
4.1.4 AFM1 sensing measurements with MRR
Guided by the results of the bulk sensitivity, photonic chips from the BS2
wafer were used for the AFM1 sensing measurements. For those exper-
iments, the microfluidic chamber was initially filled with a 50 mM MES
buffer with pH 6.6. We then injected 75 µL of a solution containing the
targeted mycotoxin at a known concentration in order to measure the evo-
lution of the resonance wavelength of the resonators due to the capture of
the toxins from the functionalized MRR. The solution is inserted into the
microfluidic chamber using an injection loop, which avoids the formation
of air bubbles in the microfluidic chamber during the buffer exchange and
allows having a known fixed injected volume. For all the measurements the
flow rate of 3 µL/min was used.
Figure 4.5a shows an example of a sensorgram measured with a solution
of 100 nM AFM1 when the surface of the MRRs on the BS2 chip has been
functionalized with the Fab’. The measurement starts with flowing the MES
buffer. The resonance wavelengths of the three exposed sensors, i.e., MRR2-
MRR4, as well as that of the reference sensor MRR1, stay constant while
flowing the buffer. We consider these resonance wavelength as a baseline.
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FIGURE 4.5: (a) Sensorgram of a complete measurement cycle for a sensor
functionalized with Fab’ and for a 100 nM AFM1 solution. (b) Sensing mea-
surements of 50 nM and 100 nM pure AFM1 and 200 nM OTA diluted in MES
performed on sensors functionalized with both aptamer (dash lines) and Fab’
(solid lines) based strategies. The flowing buffer is MES.
Then, we inject the 100 nM AFM1 solution. The solution reaches the
sensor after 2 min when we observe a large resonance shift for MRR2-MRR4
while no shift is measured for the reference MRR1. This shows that no tem-
perature fluctuations are caused by the change in the flown solution. The
MRR2-MRR4 resonances roughly follow an exponential law, due to the spe-
cific binding of AFM1 to the functionalized surfaces of the three MRR. The
binding of the toxins occur from the 2.5 min to the 25 min. At this time,
we stop the toxins flow and we switch to a MES buffer flow. This causes a
decrease in the resonance shift due to the rinsing of the physically absorbed
AFM1 from the surface. Therefore, we consider indicative of the sensor re-
sponse the value of the resonance shift after 22.5 minutes that is varying
between 33÷38 pm for MRR2-MRR4. Finally, we inject a 100 mM glycine-
HCl pH 2.3 solution at t=30 min, in order to break the AFM1-antibody bonds
and to remove all the linked toxins from the sensor surface while keeping
the antibodies in place. This regeneration solution is commonly used in sur-
face binding experiments. It perturbs the aptamers or Fab’ tridimensional
conformation, which leads to a release of the captured toxins. After glycine
solution, at t=55 min we inject again MES and the signals reach close to the
baseline indicating that the sensors are again clean. Note that the MRR1
resonance does not shift during the whole cycle. The same procedure was
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realized in case of aptamer-based functionalized sensors.
The next important step for any biosensor is to control the selectivity
against the target bioanalytes. For this purpose we performed sensing mea-
surements of another mycotoxin with the similar molecular dimensions as
well and compared the signals caused by AFM1 specific binding or Ocra-
toxin A (OTA) non-specific interaction with surface functionalization. Note,
that the molecular weight of the AFM1 is 328.27 g/mol and the OTA is
403.81 g/mol.
Figure 4.5b shows various sensorgrams for different composition of the
tested samples. Functionalization is specific to AFM1. In order to test the
specificity of the functionalization we tried the sensor with a solution con-
taining OTA. We performed sensing measurements with AFM1 at 50 nM,
100 nM and OTA at 200 nM concentrations. Both mycotoxins are diluted in
MES buffer. The protocol of the measurements is the same. For both func-
tionalization strategies, the specificity is observed. Indeed, the resonance
shift is small for OTA while it is larger for AFM1.
We then tested the reproducibility of results. We repeated AFM1 sensing
measurements for numerous chips for both functionalization strategies. Fig-
ure 4.6 shows the histograms of repeated measurements on different chips
for the same functionalization protocols and the same AFM1 solution to test
the reproducibility of the sensor response from chip-to-chip. Figure 4.6a
shows the results for aptamer-functionalized MRRs when the concentration
of injected AFM1 is 100 nM. As we can clearly observe, the resonance shift
changes between 10 pm to 220 pm. The average value with a standard devi-
ation is ≈35±60 pm showing that the reproducibility of the measurements
is poor. The source of these uncertainties can be looked for in the wafer
processing, in the functionalization procedure or in the toxin binding dy-
namics. Since wafer processing reproducibility is very high and the surface
functionalization gives reproducible results, we conclude that the low re-
producibility is related to binding steps. Figure 4.6b reports the same anal-
yses for sensors functionalized with Fab’. The distribution of the resonance
shifts on different chips is much narrower than with aptamer functionaliza-
tion (between 15 pm and 42 pm) yielding an average value and a standard
deviation of ≈25±8 pm. It is therefore concluded that the Fab’ functional-
ization is more reproducible than the aptamer one.
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FIGURE 4.6: (a) The histogram of the resonance shift of the microring resonator
for aptamer based functionalization. The average resonance shift is 35 pm with
an error of 60 pm. (b) The histogram of the resonance shift of the microring
resonator for Fab’ based functionalization. The average resonance shift is 25
nm with an error of 8 pm. Both histograms are given for 100 nM AFM1. Bin size
is 10 pm. (c) The resonance shift for different concentrations of AFM1 detected
with aptamers-based functionalization. The line is a linear regression of the
data. (d) The resonance shift for different concentrations of AFM1 detected
by Fab’. The red line is a Langmuir fit of experimental data and the blue line
shows the linear region of the dependence.
In addition, we note that the average shifts are close, within the error
bars, for the two functionalization. This differs from what observed with
the surface experiments. There are several possible explanations for this.
For the flat surface experiments, an enzyme- conjugated Aflatoxin is used,
while, for sensing measurements, a pure AFM1 is used. AFM1-HRP and
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the antibody used for Fab’ production are part of the same Elisa assay. It
could be that a higher affinity of Fab’ for AFM1-HRP occurred with respect
to aptamers. Another consideration relates to the signal measurement meth-
ods. Chemiluminescence detection of AFM1-HRP on SiON substrates gives
direct information about bound molecules, while the detected signal of the
MRRs reflects the environmental changes near to the sensor surface sensed
by the evanescent field of the guided optical mode. The evanescent field
depends on the thickness of the bound layer on the surface. In fact, the vol-
ume of interaction between the analyte and the evanescent field of the MRR
optical mode is constrained by the thickness of the layer of the captured an-
alyte. In the case of nanometric-sized molecules, this means that most of the
evanescent field of the optical mode is unperturbed and not used to produce
a signal. The molecular weight of Fab’ is around 500×102 g/mol (50 kDa),
more than three times larger than the aptamers, while the molecular weight
of AFM1 is 328.27 g/mol. The resulting bound layer is therefore far apart
for the Fab’-based functionalization than for the aptamer-based functional-
ization which decreases the interaction between the evanescent tail and the
small AFM1 molecules.
For a complete description of a biosensor, a smallest detectable concen-
tration (LOD) of target, in this case AFM1, is needed to be defined. We
performed repeated sensing measurements for various AFM1 concentra-
tions. Figure 4.6c shows the measured resonance shift dependence from
AFM1 concentration for aptamer-based functionalized sensors. In order to
obtain the smallest detectable concentration of AFM1 that can be reliably
detected, we use a linear regression to the data (line in Figure 4.6c). The
slope of the linear regression yields the sensitivity of the sensor to AFM1,
i.e., SAFM1=(0.40±0.04) pm/nM. From resonance measurements we have
a standard deviation of σλ=(0.08±0.002) pm on the measured wavelength.
This corresponds to a theoretical LODAFM1=3σλ/SAFM1=(0.6±0.1) nM.
On the other hand, if we consider the intercept of the linear regression as
a best estimate of the error σAFM1 in the concentration measurements, we ob-
tain the experimental LODAFM1=3σAFM1/SAFM1∼=(25±40) nM. For aptamer-
based strategy we observed a big scattering of data for all measured concen-
trations and thus we did not obtain saturation even for high concentrations.
In contrast, with for Fab’-based strategy, we observe the signal satura-
tion at high AFM1 concentrations (see Figure 4.6d). If we consider the de-
pendence of the shift from the small AFM1 concentrations as linear (ble line
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in Figure 4.6d), a rough estimation will give the experimental LODAFM1∼=
3×(0.20±0.03) pm/(1.20±0.01) pm/nM =(0.5±0.1) nM.
Moreover, in this case, by fitting the data with a Langmuir function
(Eq. 2.41), the dissociation constant and the affinity of Fab’-AFM1 interac-
tion can be extracted. From the fit we obtained the values of KD=(18±6) nM
and KA=(5±2)×107 M−1, respectively. Thus, the low-affinity interaction is
taking place.
Figure 4.6d shows another important observation as well. Since the sig-
nal levels for the 50 nM and 100 nM AFM1 solutions are very close, we can
conclude that 50 nM AFM1 is enough to cover all binding sites of the immo-
bilized ligands on the sensor surface. Hence, we can calculate the Fab’ sur-
face density by doing the following estimations. 50 nM AFM1 corresponds
to the ≈3×1015 molecules/L. The volume over the MRR (SiON waveguide
surface) is≈5×10−11 L (the height of the microfluidic is≈100 µm). Thus, the
number of AFM1 molecules over the MRR sensing area is 154. Let us con-
sider that all the AFM1 molecules are bonded by the Fab’ molecules, from
where we get ≈2.5×10−9 mol Fab’ on the MRR surface. The sensing surface
of the MRR waveguide is 560 µm2, which yields the Fab’ surface density of
≈5×10−4 mol/cm2, equivalent to 25 g/cm2 (the Fab’ molecular weight of
50 kg/mol).
Finally, let us note, that even if the LODAFM1 for the Fab’-based function-
alized MRR sensors is 50 times smaller then for the aptamer functionalized
ones, however in both cases the LODAFM1 is larger that what EU regulations
allow, i.e., 152 pM for adults and 76 pM for infants. Thus we conclude that
our MRR sensors are not suitable for AFM1 detection.
4.2 aMZI for AFM1 detection
The aMZI chip used in sensing experiments is shown in Figure 4.7. All
measurements are performed using the alignment stage shown in § 3.2.3.
Before carrying out AFM1 sensing measurements first in buffer, then in milk
samples, chips are optically characterized.
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FIGURE 4.7: An image of aMZI based chip. On the left, the bright spot on the
chip edge is the laser scattering at the input waveguide. Input and four output
waveguides are coupled with a fiber array. Blue dashed zones indicate sensing
windows.
4.2.1 Sensitivity and Limit of Detection
Figure 4.8a shows the normalized spectra of all four aMZIs. The transmis-
sion signals of all devices are normalized to the maximum signal of the one
from the covered aMZI. FSR for open ones are the same and equal to 0.64
nm, while for the covered aMZI4 FSR is slightly different as a result of the
refractive index difference. Knowing the FSR, we can calculate the wave-
length shift from the phase shift in nm-s, considering that 1 rad ∼= FSR2pi =
0.1014 nm. For the further discussions the phase shift will be presented in
nm-s. This is convenient to do for in order to compare our aMZI sensors
with the various configurations.
Next, we defined the performances of our photonic sensors, by charac-
terizing the volume (bulk) Sensitivity (Sb) of the three uncovered aMZIs. To
calculate this parameter, we monitored in real-time the phase shift of the
aMZI, as one arm of the sensor was exposed to glucose-water or salt (NaCl)
solutions of various concentrations.
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FIGURE 4.8: (a) Normalized transmission spectra of all four aMZIs. (b) The
variation in refractive index is obtained by injections of water-glucose and salt
solutions at different concentrations (glucose and NaCl concentrations are in
%w/v labelled on the plot). (c) Corresponding wavelength shifts linear fit
where the slope is the sensitivity. (d) Shift taken in 24 seconds correspond-
ing to the period of 11.6÷12.0 minutes on the sensorgram marked inside the
black square. The legend is the same for a, b and d plots.
We tested two different types of solutions in order to ensure that the
sensitivity is independent from tested solutions. The measurement started
with flowing pure water, which served as a reference liquid. The initial
phase was determined when only water was flowing.
Figure 4.8b represents the shifts in nm as a function of the bulk refractive
index variations measured simultaneously on four aMZI. Injection of the
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glucose or salt solutions caused a significant shift, which was similar for the
three sensors on the chip. Since aMZI4 was covered by cladding, the change
of the flowing liquid over its surface did not lead to the wavelength shift.
Before passing to glucose-water solutions, we injected pure water from the
same reservoir of the flowing liquid and a small shift was caused by the
temperature differences of the solutions injected from the valve and flow-
ing inside the tubings. This shift later is considered as the baseline. Then,
glucose-water solutions are injected at different concentrations.
Figure 4.8c shows the dependence of the shift versus the refractive index
of the solution, i.e. the bulk sensitivity. We found a sensitivity of (950±5)
nm/RIU and (1020±10) nm/RIU respectively for NaCl and glucose solu-
tions for all the three exposed sensors. This small difference between sensi-
tivities can be a result of the density difference, since in the same range of
concentrations (note, concentrations are in %w/v), expressed as percentage
there are more molecules of salt than glucose. Nevertheless, this difference
is negligible and the fact that after each salt solution the signal is recovering
yields that salt does not adsorb on the sensor surface. Finally measuring
an average standard deviation of the signal σ=(2.0±0.5)×10−4 nm within
24 seconds (see Figure 4.8d) when analyte is missing, we calculated LOD
∼= (6.0± 0.5)× 10−7 RIU.
In order to verify the reproducibility, we repeated volumetric sensing
measurements for more than 60 different photonic chips (all tested photonic
chips before AFM1 measurements underwent volumetric sensing measure-
ments). Figure 4.9 represents the resulting histograms for Sb and LOD,
demonstrating a good reproducibility that permits to neglect any additional
influence on the toxin sensing from the photonic point of view. A ≈10%
spread for the mean value of the sensitivity is observed which is an indi-
cation of the repeatability of the sensor fabrication and testing. The mean
value for bulk sensitivity is calculated to be Sb≈(1250± 150) nm/RIU, while
the mean value of LOD≈ (1.2± 0.3)×10−6 RIU.
In comparison with the sensitivity and LOD of the MRR sensors, one
can see that the aMZI sensors have ≈10 times higher bulk sensitivity, while
the LOD is in the same order of magnitude, i.e., in the range of 10−6 - 10−7
RIU. Thus, our aMZI sensors are comparable with other configurations (see
Table 1.2). The big difference between the sensitivities of the MRRs and
aMZIs is a result of a longer sensing length in a case of the aMZIs.
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FIGURE 4.9: Statistics for the sensitivity and LOD for about 60 aMZI chips: (a)
The histogram for sensitivity obtained by volumetric sensing measurements.
The mean value is (1250±150) nm/RIU, even though the best measured sensi-
tivity is (1600±100) nm/RIU. Bin size is taken 100 nm/RIU. (b) The histogram
for LOD shows the distribution of LOD with 2×10−7 RIU bin size. The calcu-
lated minimum LOD is (4.8±1.0)×10−7 RIU. However the mean value for LOD
is (1.2± 0.3)× 10−6 RIU.
4.2.2 aMZI surface functionalization with Fab’
Considering the results on the aptamer and Fab’ based functionalization
strategies, and the fact that aMZI are more sensitive, for AFM1 detection
in milk aMZI sensors functionalized with Fab’ are used. The surface func-
tionalization is performed by Dr. Cristina Potrich. Fab’ are immobilized
on the Si3N4 surface adapting the protocol described in § 4.1.3.2, with some
modifications related to the final step of the functionalization protocol. Fig-
ure 4.10 represents the schematics of Fab’ functionalization approach with
the AFM1 detection as the final step. Hence in the milk samples there are
casein molecules present and the non-specific absorption of the casein on
the Si3N4 surface can cause a significant fake signal parallel to the one from
the Fab’-AFM1 specific binding, thus an addition step of casein passivation
was carried out in order to reduce the casein non-specific effect in final milk
sample tests.
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FIGURE 4.10: Schematics of the surface functionalization principle. Fab’ frag-
ments are prepared starting from whole antibodies (images of IgG and Fab’ are
adapted from structures deposited in the Protein Data Bank [131]). Fab’ are
bonded to the mercapto-silanized sensor surfaces with a disulfide bond. The
non-reacted thiol groups are passivated by adding mercapto-PEGs (both 2.000
and 5.000 Da), while the non-specific binding sites still present on the surface
are passivated with casein. Note, that the molecule sizes are not scaled and are
not corresponding to the real proportions.
The functionalized chip is exposed at 0.1mg/ml of casein solution for
30 minutes, in order to increase the chip performances in a slightly dirty
solution. The surface is finally cleaned using a PBS-EDTA buffer. The con-
centration of the Fab’ is determined by measuring their absorbance with a
Nanodrop instrument (Extinction coefficient (0.1%)=1.35 at 280 nm).
4.2.3 AFM1 sensing measurements in buffer
Figure 4.11a shows one complete measurement cycle. This includes toxin
injection and regeneration of the sensors.
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The measurement starts with flowing 50 mM MES buffer with pH 6.6
over the sensors. The phase of the three exposed sensors stays constant
while flowing the buffer. We consider this phase value as the phase base-
line. Next, the injection of 50 µL of a solution containing 10 nM AFM1 is
followed in order to measure the evolution of the phase and, consequently,
the wavelength of the aMZI due to the capture of the toxins from the func-
tionalized aMZI.
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FIGURE 4.11: (a) Sensorgram recorded on the four aMZI sensors for a complete
measurement cycle of 10 nM AFM1 solution. (b) Sensorgram for the specific
detection of AFM1 compare to the one for non-target OTA at 10 times higher
concentration.
The solution is inserted into the microfluidic chamber using an injection
loop in order to avoid the formation of air bubbles in the microfluidic cham-
ber during the buffer exchange and to have a known fixed injected volume.
All measurements were done with a flow rate of 5 µL/min.
The solution reached the sensor surfaces after 40 seconds when we ob-
served a large phase shift and, then, the phase grew almost linearly due to
the specific binding of AFM1 to the exposed surfaces of the three aMZI. It
looks like the binding of the toxin occurred between 2,5 and 7,5 minutes.
A subsequent flow of MES buffer caused a decrease in the phase due to
the rinsing of the unbound AFM1 from the sample surfaces. However the
phase do not recover to the initial value due to the stable AFM1 binding on
the surface, which is not rinsed with the subsequent flow of buffer solution.
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The phase shift in time follows the kinetics of the binding and dissociation
of the toxin to the antibody on the surface of the exposed aMZI arms. Fi-
nally, we injected a glycine solution at the 20th minute, in order to break the
toxin-antibody bonds and remove all the linked toxins from the sensor sur-
face while keeping the antibodies in place: i.e., we aimed to regenerate the
sensor. After glycine solution at the 28th minute we injected MES again and
the signal recovered the baseline. This means that AFM1 were completely
removed from the surfaces of the sensors.
Note, that the functionalization aims at detecting AFM1 and not OTA, so
this experiment allows testing the specificity of the sensor response as well.
For this purpose we used OTA at 100 nM concentration. Figure 4.11b shows
that even though the concentration of OTA is ten times higher than concen-
trations of AFM1, the non-specific signal is much lower in comparison with
the specific signal. In fact, in the case of AFM1 at 10 nM, immediately before
MES rinsing, the shift is 0.55 nm, while for OTA at 100 nM it reaches 0.16
nm. Note, that OTA related shift is not absolute and from chip to chip it can
change, it is important that the difference of specific and non-specific signals
remain stable for different chips.
A big number of chips functionalized with Fab’ are tested for AFM1 var-
ious concentrations. We used different flow rates in order to optimize the
sensor. As expected, flow rate does not affect significantly on the signal
level. Figure 4.12a represents the sensorgram of 10 nM AFM1 detection,
when the flow rate of the continuous flow is varying. The average shift
corresponds to (0.4±0.05) nm. In further analyses for all concentrations we
present an average value calculated from all measurements at given concen-
tration.
Figure 4.12b shows the wavelength shift dependence versus AFM1 con-
centration. The difference between signal levels is mainly caused by Fab’
degradation in time even though the functionalization and measurement
protocols are always kept the same. For all measurements Fab’ bought in
December 2015 is used.
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FIGURE 4.12: AFM1 measurements in MES buffer. (a) Sensorgram shows bind-
ing curves of AFM1 at 10 nM in case of various flow rates. (b) Shift due to AFM1
specific binding performed in different dates (seasons). (c) Normalized shift on
the maximum signal of each season. (d) Normalized shift fit with Langmuir
isotherm.
In order to compare results from different dates (seasons) of measure-
ments all data are normalized on the maximum signal observed for the
specific period (see Figure 4.12c). When we plot together all data points
from 0.5 nM to 50 nM, we obtain a curve that is well fitted with a Lang-
muir isotherm. From the fit we extract the value of the dissociation con-
stant (see Figure 4.12d), i.e., KD=(12±5) nM. Note, that for MRRs for disso-
ciation constant of Fab’-AFM1 binding we calculated KD=(18±6) nM. This
results prove the specific performance of the functionalized surface. For
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the AFM1-Fab’ binding affinity we get KA=(8±3)×107 M−1. Therefore, the
known affinity of this product family is in the range4 of 109-1011 M−1 .
It is well known that molecular interactions, consequently, the rate con-
stants are highly dependent from the flow rate, temperature, and surface
functionalization, thus here we discuss a set of measurements performed
on fresh functionalized and measured aMZI in the same day, keeping all
parameters of the measurements constant, except the toxin concentration.
We used 0.5 nM, 5 nM and 50 nM AFM1 concentrations (see Figure 4.13a).
The flow rate was set at 10 µL/min. The volume of the injected solution
was 70 µl. In order to calculate the dissociation constant from these mea-
surements we derive it from the association and dissociation rate constants,
as it is described in Chapter 2. We perform exponential fit for each of the
curves between ∆t=10÷190 seconds where the association takes place, as it
is shown in Figure 4.13a.
Figure 4.13b shows the dependence of kobs from the AFM1 concentration.
The error bars represent the variation of kobs resulting from the fit in ∆t±10 s
intervals. From the linear fit of kobs as a function of the AFM1 concentration,
we can extract values for kon and ko f f . The association and dissociation rate
constants are found to be (2.2±0.2)×105 M−1s−1 and (1.1±0.04)×10−2 s−1
respectively. Using Eq. (2.40) for the dissociation constant we get KD=(50±5)
nM and for the affinity KA=(2±0.2)×107 M−1, respectively. Obtained values
are in the same order of magnitude as the ones extracted from the Langmuir
isotherm.
4http://www.abcam.com/aflatoxin-antibody-1c6-ab685.html
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FIGURE 4.13: Sensing measurements of 0.5 nM, 5 nM and 50 nM AFM1 in MES
buffer. (a) Sensorgrams for AFM1 different concentrations. (b) The dependence
of the pseudo-first-order rate constant for AFM1 concentrations. Slope and in-
tercept of the linear fit correspond to kon and ko f f . (c) The shift of AFM1 differ-
ent concentrations. The red line is the linear fit for the small concentrations.
Finally, we can estimate the experimental LODAFM1 in a buffer solution
for the aMZI based sensors functionalized with Fab’. Figure 4.13c shows
the dependence of the maximum shift at t=380 s from the AFM1 concentra-
tion. The error bars show the variation of the shift at 380±20 s. The very
small variation shows that the reaction is close to the equilibrium phase. By
fitting the linear part of the dependence, for the slope of the linear regres-
sion, corresponding to the sensitivity, we get SAFM1=(5±0.7)×10−2 nm/nM,
while the intercept can be considered as a best estimate of the error σAFM1
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in the concentration measurements. Thus, the of LODAFM1=(3±1) nM is cal-
culated. Note, that this concentration is higher than the one required by the
EU regulations. For this reason the concentrator module is integrated to the
final detection system.
4.2.4 Proteins in milk samples
As it is known, milk is a complex substance that contains different molecules
of various sizes, i.e., proteins, sugars, vitamins, etc. AFM1 has relatively
small dimensions (327 g/mol) in comparison with proteins, in particular
with casein (≈ 22±3 kg/mol) [132] present in milk. One of the biggest chal-
lenges for any biosensing system meant for AFM1 detection, is non-specific
signal from proteins adsorption.
Therefore, during SYMPHONY project by our partner ACREO first the
blank samples are prepared, without AFM1, that contain known amount of
protein. Those samples are measured in UNITN. A flow rate of 15 µL/min
is used. As it is presented on the sensorgram in Figure 4.14a, a clear depen-
dence of the signal level from the protein concentration is observed. Two
different samples with the same 80 mg/L concentration of protein show a
signal level of 4.5 nm and 4.3 nm (black and red curves), while for 60 mg/L
protein concentration a signal of 2.9 nm (blue curve) is measured. These
results show the need to perform a filtration of milk samples.
Next, the milk sample with measured 70 mg/L of proteins and 0.16 nM
(≈50 ng/L) of AFM1 concentrations undergoes a filtration with 3 kDa cen-
trifugal filters (ELISA tests were performed in ACREO). Samples before and
after filtration are tested. Figure 4.14b presents the sensorgram reporting
measurements both on unfiltered and already filtered milk samples. A clear
difference between the sensorgrams, recorded for these samples is distin-
guishable. Besides the signal levels, one can also appreciate the difference
of binding kinetics proving the specific interaction of AFM1 with Fab’, when
proteins are removed from milk (see the red square in Figure 4.14b).
Filtration approach is used in the SYMPHONY final system, during the
defatting step. Nevertheless, some proportion of proteins still remain in the
prepared samples. For this reason each time before AFM1 measurements, a
blank sample is tested and the resulting signal is considered as a baseline or
0 for further toxin analyses.
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FIGURE 4.14: Sensorgram reports (a) a non-specific signal dependence from
protein concentration, present in milk, (b) resulting difference of the signal
when proteins are filtered from the milk.
4.2.5 AFM1 detection in milk samples
The final goal of the biosensor, developed in this thesis is the fast and ac-
curate detection of AFM1 in milk samples. Therefore, we tested our de-
vice with the milk samples prepared with the procedure described in Ap-
pendix B.2. To achieve a fast detection, the sensing duration was reduced
down to 90 seconds. This was done by increasing the flow rate up to 20
µL/min and by decreasing the injected solution volume down to 30 µL.
The level of AFM1 in tested samples was first analyzed with the ELISA
assay. It is important to mention that the actual concentration of toxin was
the result of the system concentrator block that concentrates the toxin in
the eluate. For each concentration, we used freshly functionalized and opti-
cally characterized chip. This was done in order to avoid surface functional-
ity degradation after regeneration process. The surface preparation process
was highly repeatable for the same set of the functionalization processes.
Different sets of milk samples measurements have been performed, there-
fore here we present the results of the final project demonstration including
all optimizations of the complete system.
First test of milk was performed on a sample free from AFM1, as a refer-
ence for the system. Note, that in the prepared samples still some proportion
of proteins, in particular, casein remains, which causes a non-specific signal.
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The non-specific adsorption of milk component even on passivated surfaces
is a known phenomenon [133]. For further analysis, we consider this signal
as a baseline equal to 0. Next, injecting the milk samples containing 0.96 nM,
1.3 nM, 1.5 nM and 2.2 nM AFM1 we observed a wavelength shift, which
increased with the concentration increase, as shown in Figure 4.15a. A clear
difference of the signal levels and kinetics between the reference sample and
the ones with AFM1 indicates that a specific interaction between AFM1 and
Fab’ takes place, as expected.
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FIGURE 4.15: Sensing measurements of 0.5 nM, 5 nM and 50 nM AFM1 in
MES buffer. (a) Sensorgrams for different concentrations of AFM1. (b) The
dependence of the pseudo-first-order rate constant of the AFM1 concentrations.
Slope and intercept of the linear fit correspond to kon and ko f f .
From the exponential fit of the curves in the (40÷90)±10 seconds inter-
val, where the association occurs, we obtain a linear dependence of the rate
constant versus the AFM1 concentration, as shown in Figure 4.15b. The er-
ror bars show the rate constant variation in δt=10 s. From the linear fit of
kobs as a function of the AFM1 concentration, we extract values for kon and
ko f f respectively (1.3±0.5)×107 M−1s−1 and (6.5±0.5)×10−3s−1. Taking the
dissociation constant as the ratio of kon and ko f f , KD = (0.5±0.2)×10−10 M
and affinity KA = (2±1.5)×109 M−1 values are calculated. All these values
are in a range similar to the reported values for aptamers specific for AFM1
binding [134], while, to the best of our knowledge, this is the first time that
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kinetic constants are measured for the interaction of AFM1 with Fab’ both
in buffer and in real samples. The difference of two orders of magnitude
between the affinities in buffer and milk samples, respectively, is caused by
several aspects. For example, in the tested milk samples there were present
additional salts and molecules which could severely affect the interaction
between AFM1 and Fab’. Moreover, the components present in real samples
could be adsorbed on the surface via non-specific interactions and mask the
binding sites specific for AFM1 with the final effect to slow down the kinetic
and to decrease the affinity constant measured in milk samples.
4.2.6 Sensor calibration
After the successful demonstration of AFM1 detection in milk, the sensor
calibration was realized based on the results presented above. For this set of
measurements AFM1 was concentrated by a factor ≈20.
Figure 4.16 shows the dependence of the maximum observed shift (at
t=90 s) versus AFM1 concentration in the milk samples. The error bars show
the shift variation in 10 seconds.
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FIGURE 4.16: Calibration curve of the sensor based on aMZI functionalized
with Fab’. With this device the lowest detectable concentration of AFM1 is
calculated to be (0.8±0.2) nM.
4.3. MRR sensors for anti-biotin analyses 113
For the small concentrations the increase of the shift is slow, while for
the highest concentrations a higher slope is observed. As a 0 shift the signal
from the blank sample is taken. By fitting the data with a Langmuir function,
the lowest concentration of AFM1 that can be measured is defined (0.8±0.2)
nM. Moreover, recalling the sample pre-concentration up to 20 times, the re-
sulting LOD of≈ (40±1) pM is achieved, that is lower than the requirements
of EU regulations, i.e. 152 pM for adults and 76 pM for infants.
4.3 MRR sensors for anti-biotin analyses
The last section of this chapter is dedicated to the work done during my
internship under the supervision of Dr. Geert Besselink in LioniX Interna-
tional. This study aimed to develop an affinity sensor for studying the in-
teraction of biotinylated proteins and antibodies, in particular bovine serum
albumin (BSA) and anti-biotin antibody. For this purpose a photonic chip
based on six MRRs, presented in Figure 3.3 is used. A relatively fast and
easy method for anti-biotin antibody affinity (KA) and dissociation constant
(KD) measurement is demonstrated, as well as the reaction rate constants
for this system are reported. Moreover, a fully regeneration of the sensor is
achieved. It is quite tricky to achieve the regeneration protocol for this type
of systems since it requires a regeneration solution that cleans the surface
from bound molecules but, at the same time, does not damage the coating
and the surface functionalization. Different approaches are proposed for
system regeneration [71, 135], which highly depends on the specific func-
tionalization and target molecules. Here we propose a method which has
the main advantage of being able to regenerate the same chip up to eight
times without damaging the sensor characteristics. Finally the specificity of
our functional system is demonstrated by comparing the resonance wave-
length shift for negative controls such as rabbit antibody and anti-biotin in-
cubated with free biotin.
4.3.1 Sensitivity and Limit of Detection
As in the previous two cases, we firstly perform a sensor characterization in
terms of bulk sensitivity and LOD. We monitored in real-time the resonance
wavelength shift of six MRRs simultaneously, by flowing various sucrose
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solutions over the sensor. The measurement started with flowing MilliQ, as
a reference liquid for defining the baseline. Figure 4.17a represents the res-
onance shifts as a function of the bulk refractive index variations measured
on six MRRs in parallel. All the MRRs behave rather similarly.
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FIGURE 4.17: Bulk sensitivity measurements. (a) resonance shift curves for all
six MRR sensors during the injection of the MilliQ-sucrose solutions (sucrose
concentration5in ◦Brix is labelled on the plot), (b) evaluation of the bulk sensi-
tivity.
Figure 4.17b shows the relation between the sucrose concentration (i.e.,
refractive index of the cladding liquid) and the resonance shift. Since the
bulk sensitivity is a ratio of the wavelength shift over the refractive index
change of the cladding liquid (Sb=dλres/dnc), from the linear fit of the reso-
nance shift vs sucrose concentration the value of bulk sensitivity is obtained.
We obtain a sensitivity of (98±2) nm/RIU, while the variation among all six
MRRs was less than 2.2%. This fact allows us to use this kind of sensor chip
for multianalyte detection. In the work[50] it is previously reported a simu-
lated value of 98nm/RIU for the sensitivity. In the same work it is also re-
ported the quality factor of the MRR, i.e., Q=1.5×104. The LOD of the system
is calculated considering a standard deviation equal to σ=(0.3±0.02)×10−4
nm. Using Eq. 2.4 the LOD=(9±0.5)×10−6 RIU is obtained.
51◦Brix is 1 gram of sucrose in 100 grams of solution (MilliQ).
4.3. MRR sensors for anti-biotin analyses 115
Note, that the sensitivities and LOD for both MRR sensors, discussed in
this thesis, are in the same order of magnitude, although the SFBK=(80±12)
nm/RIU<(98±2) nm/RIU=SLioniX. This difference is a result of the waveg-
uide dimensions, as well as the effective refractive index differences (ne f f ,FBK
=1.66<1.99=ne f f ,LioniX).
4.3.2 MRR surface preparation with Neutravidin
The preparation of the biorecognition layer on the MRR SiO2/Si3N4 surface,
i.e., the chemical coupling of Neutravidin and the next step of the capturing
of biotinylated BSA can be monitored using the MRR resonance wavelength
measurements. In order to immobilize biotinylated BSA for anti-biotin stud-
ies, first we performed protein Neutravidin (100 µg/ml in MES) direct phys-
ical adsorption on the SiO2/Si3N4 surface. If the efficiency of adsorption
would be satisfying this method is economically profitable and easy to real-
ize. But as it is shown in sensorgram of Figure 4.18a, the physical adsorption
was not equally distributed on all MRR on the chip and consequently later
sensing measurements would not be compatible. On the figure the signal
from only three out of six MRR are presented due to the measurement dis-
turbance by air bubbles.
After flowing Neutravidin on the chip surface, the observed wavelength
shift reflected the physical adsorption and layer formation. For the first two
sensors we measured a shift of 0.06 nm, while the third one achieved 0.1 nm
resonance wavelength shift. The difference of signals between MRR3 and
other two was 45%.
Since the method was not reproducible, we moved to an alternative
method, i.e., the covalent coupling of Neutravidin to the sensor surface. The
functionalization of the chip surface with a carboxylate layer was applied
by Surfix BV (Wageningen, The Netherlands) using their proprietary alkene
technology. Then at Lionix International BV a multi-step approach is fol-
lowed in order to achieve immobilization of biotinylated BSA. First the car-
boxylate groups were activated with EDC/NHS (0.4 M EDC/0.2 M NHS in
10 mM MES, pH 5.3), then coupling of the protein Neutravidin (100 µg/ml
in MES) to the chip surface via reaction of the protein amino groups with
the NHS-activated carboxylate groups is performed. Finally, the capturing
of biotinylated BSA (25 µg/ml in PBS) by the immobilized Neutravidin is
allowed to proceed.
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FIGURE 4.18: Sensorgram recorded on MRR sensors when: (a) Neutravidin
(10 mM MES) physically adsorbed on the surface and then Biotinylated BSA
is injected. (b) covalent coupling of Neutravidin (10 mM MES) was pursued
onto the EDC/NHS activated carboxylated coating followed by the capturing
of biotinylated BSA (in PBS).
Figure 4.18b shows a typical sensorgram that is obtained during the cou-
pling of Neutravidin onto EDC/NHS activated carboxylated coating of the
MRRs surfaces. At t=0 min MES buffer is flowing over the MRRs. After
few seconds 100 µg/ml Neutravidin in MES buffer is injected with oscil-
lating flow regime at 0.4 µL/s flow rate. From t=0.5 min to t=11 min the
coupling of Neutravidin takes place. At t=11 min MES buffer again arrives
to the sensors and the fact that the responses are not decreasing indicates the
strength of the Neutravidin binding to the coated surfaces. At t=12 min PBS
buffer replaces the MES buffer and a bulk shift is observed. Next the treat-
ment with 1M aminoethanol (pH 9.3) is performed in order to quench the
residual NHS activated groups and to dissociate any non-covalently cou-
pled Neutravidin. At t=25 min again PBS buffer is injected to prepare for
the biotinylated BSA immobilization. At t=28 min, 25 µg/ml biotinylated
BSA (in PBS) is injected. A significant shift of 0.25 nm is observed for all
six MRRs, after PBS buffer injection at t=40 min. Even though the variation
between the individual MRR responses for Neutravidin is about 7%, i.e. 0.7
nm÷0.75 nm decreasing from the first to the last MRR, all the MRRs respond
to the biotinylated BSA binding with a similar wavelength shift (±0.01 nm).
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This last observation is very relevant since it allows to asses reproducibil-
ity in the 6 MRRs as what concerns the interaction of biotinylated BSA and
anti-biotin antibody. The repeatability of the measurements is also achieved
from chip-to-chip.
A sensor prepared this way can be modeled with the 1:1 binding scheme.
4.3.3 Anti-biotin sensing measurements
Since the bulk sensitivity measurements show that all six MRRs on the same
chip have the same performances, in the next discussions only one MRR
sensorgram will be used.
Sensing measurements are realized by using an oscillating flow sup-
ported by the pump described in § 3.4.2. Figure 4.19a shows the binding
curves for six different concentrations of anti-biotin antibody equal to 6.6
nM (1µg/ml), 33 nM (5µg/ml), 66 (10µg/ml) nM, 132 nM (20µg/ml), 333
nM (50µg/ml) and 1065 (160µg/ml) nM6, that are injected from the smallest
to the highest concentration, after successfully regeneration cycle. Before
and after the analyte injection, the MRR sensors are rinsed with a solution
of PBS+0.1%BSA. While choosing the concentrations, a knowledge of the
affinity and dissociation constant of biotinylated BSA - anti-biotin interac-
tion can be useful. The affinity constant KA for this particular molecular
pair is in the range of 106 M−1 to 108 M−1.
The Langmuir isotherm for these values of KA is simulated to be within
the violet region shown in Figure 4.19b. Normalizing to the maximum shift
of the 1650 nM anti-biotin data, the measured points (red dots in figure)
appear into the expected region. By fitting the data with the Langmuir func-
tion (black line) the affinity and dissociation constants can be extracted. Fit
yields values of KD=(2.0±0.5)×10−7 M and KA=(5.0±1.5)×106 M−1 for dis-
sociation and affinity constants, respectively.
6The molecular weight of anti-biotin is 150 kg/mol.
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FIGURE 4.19: (a) Sensing measurements of 6.6 nM, 33 nM, 66 nM, 132 nM,
333 nM and 1650 nM anti-biotin antibody diluted in PBS+0.1% BSA buffer. (b)
Langmuir isotherm for the dependence of the sensor response on the concen-
tration of anti-biotin. The violet region corresponds to affinity constant of 106
M−1 ÷ 108 M−1. (c) The dependence of the pseudo-first-order rate constant
for anti-biotin different concentrations. Slope and intercept of the linear fit are
kon and ko f f . (d) Sensorgram of the sensor due to 333 nM anti-biotin antibody
(black curve), 333 nM rabbit antibody (red curve) and 333 nM anti-biotin anti-
body incubated with free biotin (blue curve).
An alternative way to calculate the dissociation constant is to derive it
from the association and dissociation rate constants, as it was done for the
AFM1 cases both in buffer and the milk samples. In order to get equilib-
rium, incubation times much longer than 12 minutes are needed. Therefore,
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we perform exponential fit for each of the curves between t=1÷7 minutes.
The fitted values of kobs show a linear dependence from the antibody con-
centration (see Figure 4.19c). Error bars correspond to the fit interval of t±30
s.
From the linear fit of kobs as a function of the antibody concentration
C, we can extract values for kon and ko f f . The association and dissociation
rate constants are found to be (7.5±0.5)×103 M−1s−1 and (5±0.5)×10−3 s−1
values respectively. From these two rate constants, a dissociation constant
of KD=(6.5±0.1)×10−7 M and an affinity KA=(1.5±0.5)×106 M−1 are calcu-
lated. This value of the affinity constant again belongs to the known range.
The order of magnitude agreement between the values calculated by
both methods confirms the validity of the measured data and shows that
it is possible to perform precise analyses of affinity and kinetics in 2 hours,
by considering about 13 minutes measurement time for each concentration
injection and then sensor regeneration.
Finally, in order to determine the level of specificity, we perform sensing
measurements by using negative control rabbit antibody at 333 nM concen-
tration, as well as anti-biotin antibody at 333 nM pre-incubated with free,
i.e., dissolved, biotin at 10 µM in 1% DMSO buffer. Figure 4.19d shows
the sensorgrams. For anti-biotin (black curve), the response from specific
bindings reaches 0.68 nm, while for rabbit antibody (red curve) after rinsing
with PBS+0.1% BSA nearly no binding is observed. Similar situation hap-
pens while injecting anti-biotin at 333 nM concentration incubated with free
biotin (blue curve). Incubation of antibody and free biotin is performed for
10 minutes before injection. After injection, we immediately observe a bulk
shift of 0.18 nm due to the refractive index difference between the DMSO
and the PBS+0.1% BSA buffers. Thus, when PBS+0.1% BSA again arrives to
the sensor, the resonance wavelength returns to almost the initial value. A
resulting shift of only 0.02 nm is achieved which indicates the specificity of
the used sensor functionalization.
4.3.4 Regeneration Measurements
One of the big advantages of the proposed biosensors is the possibility to
regenerate and reuse the same photonic chip several times without an ad-
ditional surface recovery. It is challenging to find a right regeneration so-
lution that will completely remove the bound analytes while not damaging
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the functional layer on the sensor surface. A regeneration protocol that is
investigated during this study uses 10 mM glycine/HCl pH 1.5 and needs
long incubation times. Here we compare two regeneration processes with
different durations.
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FIGURE 4.20: Average shift of six MRRs for 8 cycles of regeneration. (a) sig-
nal decrease is observed when the regeneration with 10 mM glycine/HCl pH
1.5 is performed for less than 10 minutes. For all measurements, anti-biotin at
333 nM concentration is used (b) the stability of signal is achieved when the
regeneration with 10 mM glycine/HCl pH 1.5 is performed for 20÷25 minutes.
Different anti-biotin concentrations (132 nM and 333 nM) are used in order to
prove the sensors ability to distinguish different concentrations after few re-
generation cycles.
Figure 4.20a shows the resonance shift dependence of anti-biotin mea-
surements for eight consequent cycles. Each data point presents an average
of the six simultaneous signals and with corresponding error bars. In this
case the regeneration incubation time for the six MRRs is less than 10 min-
utes. After each injection of the same 333 nM concentration of anti-biotin
antibody, the sensor response decreases and the MRRs do not behave com-
parably (big error bars are the evidences). This indicates that the regenera-
tion is not equally realized for all the six sensors and that after 10 minutes
of 10 mM glycine/HCl pH 1.5 at 2µL/s unidirectional flow there are still
analyte molecules bound to the ligands which decrease the sensor response
to the next analyte injection. After 8 injections, more than 80% of the initial
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signal is lost and only (0.13±0.02) nm shift is detected, while for the first
injection a shift of (0.55±0.03) nm is achieved.
The situation is different when a longer incubation (20÷25 minutes at
2µL/s) is used. From Figure 4.20b it is obvious that with longer regenera-
tion procedure we are able to recover the maximum response to anti-biotin
at 132 nM concentration. In contrast to the previous case, here smaller er-
ror bars are obtained, indicating that all the six MRR sensors are equally
regenerated. As a comparison, with short incubation times, when at the 8th
injection the wavelength shift is (0.13±0.02) nm only, for long incubation
times and for the same anti-biotin concentration at 333 nM, a wavelength
shift of (0.3±0.01) nm is detected.
For the affinity and kinetic analyses six subsequent measurements are
enough for reliable analyses, which makes the proposed regeneration pro-
tocol satisfying. In total for each concentration of analyte the measurement
lasts at most 35÷40 minutes.
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Appendix A
Materials and solutions
A.1 AFM1 sensing buffers
MES buffer, pH 6.6 1:
• MilliQ water,
• 50 mM 2-(N-morpholino)ethanesulfonic acid.
PBS buffer, pH 7:
• MilliQ water,
• 50 mM PBS mixture.
A.2 Sensor regeneration solution
Glycine, pH 2 :
• 100 mM glycine,
• HCl as needed to adjust the pH value.
A.3 Biological materials for AFM1 detection measure-
ments
3-mercaptopropyltrimethoxysilane (MPTMS, 99%) is purchased from Gelest
Ltd. (Maidstone, Kent, UK), was used without any further purification.
1Note, that pH 6.6 is the same as milk.
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Toluene anhydrous (99.8%), toluene, dithiothreitol (DTT) and all powders
for buffered solutions were purchased from Sigma-Aldrich s.r.l. (Milan,
Italy). Methoxypolyethyleneglycolthiol (mPEG-SH) with the 2000 and 5000
molecular weights were purchased from Nektar Therapeutics AL (Huntsville,
AL, USA). A rabbit polyclonal anti-AFM1 antibody and a horseradish per-
oxidase (HRP)-conjugated Aflatoxin M1 (AFM1-HRP) containing in I’screen
Afla M1 milk Elisa kit were purchased from Tecna s.r.l. (Padua, Italy), while
Aflatoxin M1 and Ochratoxin were purchased from Sigma-Aldrich s.r.l. (Mi-
lan, Italy). SuperSignal West Femto Chemiluminescent Substrate was pur-
chased from Thermo Scientific (Rockford, IL, USA). The amino-modified
DNA-aptamer sequence (5’-NH2-(CH2)6-GT TGG GCA CGT GTT GTC TCT
CTG TGT CTC GTG CCC TTC GCT AGG CCC ACA-3’) was HPLC prified
and purchased from IDT Integrated DNA (Leuven, Belgium).
A.4 Biological materials for anti-biotin analysis
The following materials are used: bovine serum albumin (BSA) (essentially
fatty acid free, >96%), phosphate buffered saline (PBS) tablets, sucrose (>99.5
%), 2-(N-morpholino) ethanesulfonic acid (MES), glycine, dimethyl sulfox-
ide (DMSO), goat anti-biotin antibody and biotin were obtained from Sigma-
Aldrich. Neutravidin (NeutrAvidin Protein), N-hydroxysuccinimide (NHS),
1-ethyl-3-(3-dimethylaminopropyl)carbo diimide hydrochloride (EDC) are
supplied by ThermoFisher Scientific. No-WeighTM Biotinylated BSA is ob-
tained from Pierce (Rockford, IL, USA).
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Appendix B
Milk sample preparation
B.1 Fat removal process
Some proteases like Chymosin (present in rennet) are known to denature
the casein fraction of milk as used in cheese curdling. In addition, low pH
and temperature are traditionally used to denature whey proteins, which
are separated from milk in the traditional “ricotta” cheese preparation. The
identified procedure described below was designed to guarantee a high re-
covery of AFM1 and low protein samples after the process. The target was
in particular to avoid loss of AFM1 in the separated protein phase since it
was previously demonstrated that AF has good affinity with proteins and is
therefore lost with normal curdling. The procedure steps are:
• adjust pH to 6.2 with Acetic acid, 5%; typ: 1.2 ml volume;
• heat to 30◦C;
• add solution of rennet from Muchor Miehei (0.8%w/v solution, 2 ml
volume);
• wait 3 minutes, then cut in portions and mix without breaking the gel
phase;
• heat up to 88◦C, gently mixing;
• mix acetic acid (5% solution) to adjust pH to 5.5, typ: 0.2 ml;
• mix gently for 5 minutes and separate the phases by coarse cloth.
The processed sample was then filtered with the filter system described in
section 3.6.
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B.2 Eluate preparation process
The main procedures for the concentration module consisted in:
• priming of the entire system to create air bubble free environment;
• milk delivery from the defatting unit;
• bullet rinses, i.e., first using 25 mL of admixture of MES buffer and Tri-
ton x100 detergent followed by rinse using 25 mL of pure MES. It has
been demonstrated by ACREO that admixture of low concentrations
of a detergent resulted in lower protein content of eluates and did not
affect performance of antibodies;
• AFM1 release is realized by bullet heating. We let the bullet remain at
61±3 ◦C for about 6 min;
• injection of an eluate into the detector unit using syringe filled with
compressed air.
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Conclusions
In this thesis, various label-free optical biosensors have been studied.
The main part of my work was dedicated to the development of a biosens-
ing system for mycotoxin detection in milk. The mycotoxin of our interest is
Aflatoxin M1, that is categorized as a human carcinogen and can be found
in milk, nuts, maize, etc. Acceptable maximum level of AFM1 in milk ac-
cording to the EU regulation is 152 pM for adults and 76 pM for infants,
respectively. Several commercial techniques, like ELISA, HPLC, SPR exist
for AFM1 detection in milk. However, they are laboratory based and re-
quire a trained personal to run the analyses, as well they are expensive and
time-consuming.
Looking for a simple and effective method to screen the presence of
AFM1 in milk, within a European project SYMPHONY, biosensors based on
the Silicon On Insulator (SOI) Microring Resonators (MRR) and asymmetric
Mach-Zehnder Interferometers (aMZI) have been developed. The sensing is
performed by measuring the resonance wavelength shift in the MRR trans-
mission or the phase shift of aMZI caused by the binding of the analyte on
the functionalized sensor surface.
The knowledge of the label-free optical biosensors gained within the
project SYMPHONY, I used in a development of a MRR based affinity biosen-
sor for the proteins characterization.
The bulk sensitivity and the instrumental Limit of Detection for both
types of sensors have been measured by the experimental setups developed
during my PhD. The best sensitivity for the MRR based sensors fabricated
in FBK and LioniX, respectively, (80±12) nm/RIU and (98±2) nm/RIU are
measured, while for the aMZI based sensors the sensitivity of (1250±150)
nm/RIU is measured.
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The calculated instrumental LOD in all the three cases, independently
from the sensitivity differences, is in the same range of the values, i.e., 10−6
- 10−7 RIU. This range is also reported in the state-of-the-art for various
optical biosensing configurations.
The analyte sensitivity and the smallest detectable concentration of the
target molecules (sensor LOD), although, depends on the surface function-
alization and the selected ligands. For the AFM1 detection two function-
alization strategies based on the DNA-aptamers and Fab’ are developed.
Therefore, it has been demonstrated that the Fab’ functionalized sensors
are more reproducible in comparison with the DNA-aptamer functionalized
ones. Moreover, the experimental LODAFM1=(25±40) nM for aptamer and
LODAFM1= (0.5±0.1) nM for Fab’ based functionalized MRRs are estimated.
Moreover, the aMZI based sensor, functionalized with Fab’, has the experi-
mental LODAFM1=(3±1) nM.
The results for LODAFM1 arise the need of the concentrator module. The
developed SYMPHONY system consists of three main modules, which first
purify the milk sample from proteins (defatting module), then concentrate
the sample (concentrator module) in order to suffice a nominal amount of
AFM1 that reaches the photonic sensor (detector module). Even though
the goal of a miniaturized biosensing system for AFM1 fast detection is not
accomplished by the end of the project, however the integration and func-
tional realization in laboratory is completed. In particular the connection be-
tween concentrator and detector modules is realized through injection valve
and the syringe pumps.
For the tested milk samples the aMZI sensor shows the LODAFM1=(0.8±
0.2) nM. Considering the concentration factor of 20, the resulting LODAFM1
of ≈ (40±1) pM is achieved, that is lower than the requirements of the EU
regulations.
In addition, the affinity constants for Fab’-AFM1 interaction in the milk
samples is calculated for the first time. The affinity constant of KA=(2±1.5)×
109 M−1 in the milk samples and KA=(2±0.2)×107 M−1 in buffer, respec-
tively, are measured. The higher affinity in the milk samples is observed due
to the presence of an additional salt in the milk sample preparation buffer
that causes stronger ionic interactions, consequently, the stronger molecular
bindings.
In the study of the biotinylated BSA - anti-biotin interaction the affin-
ity constant of KA=(1.5±0.5)×106 M−1 is calculated using the multi-MRR
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based biosensor functionalized with Neutravidin and immobilized by the
biotinylated BSA.
The sensor regeneration protocol is developed, which allows to utilize
the same sensor chip for the multiple times. However, for the reliable anal-
yses, for each new experiment it is recommended to use a freshly function-
alized sensor chip.
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